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ABSTRACT 
 
 
Host Signaling Response to Adhesion of  
Bifidobacterium infantis 
 
 
by 
 
 
Reed N. Gann, Master of Science 
Utah State University, 2010 
 
 
Major Professor: Dr. Daryll B. DeWald 
Research Director: Dr. Bart C. Weimer 
Department: Biology 
 
 
 Investigations of the molecular binding partners of the probiotic bacterium 
Bifidobacterium longum subspecies infantis (B. infantis) and the pathogen 
Salmonella enterica subspecies enterica serovar Typhimurium LT2 (Salmonella 
ser. Typhimurium) found that these two very different bacteria bind gangliosides. 
However, these organisms lead to completely different host health outcomes 
when present in the gut. B. infantis is the founding microbial population in the 
intestinal tract of breast-fed infants. S. typhimurium is the most important food-
borne pathogen that results in humans. This study used an in vitro gut epithelial 
cell model to examine the host cellular response to adhesion of B. infantis, which 
led to an increase in intestinal epithelium survival. This observation led to a 
series of experiments to elucidate the pathway for host signaling initiated by 
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adherence of B. infantis to the host membrane to explain the increase in host 
cell survival. B. infantis adhesion induced significant (q!0.05) differential 
expression of 208 host genes. These genes were associated with increased 
broad mechanisms of cell survival that included BIRC3, TNFAIP3, and 
SERPINB9. We hypothesized that a biochemical link existed between the host 
membrane adhesion protein and the increase in cell survival, mediated via AKT. 
We tested this hypothesis to demonstrate that B. infantis interaction initiated 
signal transduction using G-proteins via phosphorylation of AKT and induced 
production of the BIRC3, TNFAIP3, and SERPINB9. This study discovered 
adhesion of B. infantis initiated activation of AKT via phosphorylation of both 
Ser473 and Thr308, which results in increased cell survival.  
(131 pages) 
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CHAPTER I 
INTRODUCTION 
 
 
 The science of microbiology and immunology, among others, owe their 
origins to studies investigating the interactions between humans and pathogenic 
microbes (135). The bulk of knowledge concerning the molecular interactions 
between eukaryotic and prokaryotic organisms is largely restricted to infectious 
disease agents and their impact on the human condition. However, throughout 
the decades increasing amounts of information about the interactions between 
humans and bacteria that do not result in disease is gaining importance with the 
rapid increase in discoveries that describe the important contribution of 
commensal and probiotic bacteria to human health and chronic disease (53).  
 The human gastrointestinal tract is home to ~10 times more bacterial cells 
than the number of somatic and germs cells in the entire human organism, which 
live harmoniously and in some cases provide health benefits to their human host 
(129). In contrast, the link between gut microbiota composition, enzymatic 
activity, and dynamic nature with human health is being associated with specific 
diseases, including arthritis, cancer, and obesity (27, 88, 143). Consequently, the 
gut microbiome project, MetaHIT, an international collaboration, was initiated to 
define the gut microbial community structure of humans around the world. The 
goal of this initiative is that it will define normal and aberrant gut flora in a 
concerted effort to adequately describe the links between microbes and the 
human condition (38, 53). 
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 The microbial community structure of this complex ecosystem is 
classically divided into parts pathogenic and commensal microbes (61). It is 
recognized to contain an extremely complex set of microbe groupings that play 
different roles depending on the host condition, immune status, and the results of 
interactions between the gut microbiota and the host. More recently, specific 
bacteria are being correlated to improved immune system function, 
gastrointestinal balance, lower incidence of diarrhea and other specific benefits 
that they deliver to the host (117). These so-called probiotic bacteria, which are 
defined as organisms that upon consumption yield the host health benefits 
beyond simply providing the host with nutrition (94), are now commercially 
available in foods that claim to increase gut health, increase regularity of bowel 
function by reducing intestinal transit time, and improve immune function. They 
have long been advocated by Mechnikov (148) who claimed they could increase 
longevity for those who consume fermented milk products containing these 
microbes. Unfortunately, until recently the specific and repeatable health benefits 
of probiotic microbes were more fiction than reality (6, 12). In the last few years, 
molecular interaction studies yielded specific molecules and mechanisms that 
probiotic microbes induce in the host during consumption (40, 45, 140, 155). 
Considering the vastly different health effects that different bacteria can provide 
to a host, more detailed and mechanistic investigations must brought to bear to 
determine what underlies the claimed probiotic benefits so that specific traits and 
known biology can be directly linked to specific host benefits. 
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 Like pathogens, probiotic bacteria must associate with the host via 
cellular interactions to bring about their beneficial changes (29). Sela et al. (133) 
defined an example of these beneficial interactions in the microbial colonization 
of human infant guts via selective growth enrichment via consumption of the 
complex oligosaccharides found in human breast milk. This leads to a rapid 
expansion of B. infantis promoting infant gut colonization by this microbial 
population in breast-fed infants (81). This organism contains a specific set of ~20 
genes needed to consume the diverse and complex oligosaccharides that are 
found in human milk. Presumably, selective growth advantages of B. infantis will 
lead to additional adhesion and health modulation in the infant. Consequently, 
adhesion is a critical step in host/microbe association. Among other actions, 
adhesion enables an intimate connection between two very different cells that 
likely initiates molecular signal transduction responses in both cells that leads to 
extensive changes to the gut epithelium as well as other tissues depending on 
the cognate receptor interactions.  
In the mammalian gut there are many different cell types that includes 
epithelial cells, as well as gut-associated lymphoid tissue (GALT), Peyer’s 
patches, isolated lymphoid follicles, microfold cells (M-cells), dendritic, and 
immune cells (B- and T-cells) (42, 104, 106). While an extensive amount is 
known about how pathogenic bacteria invade host cells (43, 66, 83, 121, 132) 
relatively little is known about the molecules that are used to bind the host cell 
that initiates the complex set of interactions used to impart their action to the 
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host. Unfortunately, very little is known about how probiotic bacteria associate 
with host cells, yet they clearly have a role in gut health through out life. 
Eukaryotic cells commonly transduce external signals into communication 
mechanisms via protein-protein interactions, small molecules crossing the cell 
membrane, and glyco-conjugate interactions (109). Each of these signaling 
methods can be activated by the adhesion of a bacterial cell to a host cell (66, 
68). Host signal transduction resulting from bacterial adhesion likely evolved from 
different and multiple adhesion molecular events and may account for various 
phenotypic reactions displayed by the host, which includes well over 100 
molecules each of which lead to multiple and interconnecting signaling networks 
inside the host cell to change the phenotype. While only a few representative 
members of the interaction types have been explored well enough to define the 
specific molecules that interact between the two cell types, let alone the different 
types of microbes and host cells, these studies are largely focused on 
host/pathogen interactions the lead to disease. Due the disease state and the 
impact to human health, the molecular interactions of infectious disease agents 
has largely focused on invasion and induced cell death (i.e. apoptosis) (43, 77, 
113, 121). These studies led to discovery of toll-like receptors, clatherin-
dependant endocytosis, chemokines, and other key host signaling pathways that 
explain disease symptoms and the molecular progression of infectious diseases 
all with the aim to reduce or mitigate the symptoms (86, 122, 156). 
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 Recently Desai et al. (31, 32) demonstrated that probiotic and various 
pathogenic bacteria bind gangliosides covalently bound to solid glass beads. 
These are the same component of the mammalian extra cellular matrix (ECM) 
and are binding partners of various molecules and pathogens, including 
Salmonella ser. Typhimurium, Salmonella enteridis, Escherichia coli, Clostridium 
botulinum neurotoxins (142), Haemophilus influenzae (22) and many viruses 
(141). However, this observation leads one to ask many intriguing questions:  
• If two very different bacteria are binding the same component of their host 
cells, what accounts for the difference in the host reaction?  
• What changes are induced by probiotic adhesion in the presence of a 
pathogen?  
• Can molecular binding events account for claimed health benefits of 
probiotic bacteria?  
• What signal transduction routes are changing that lead to a non-
pathogenic outcome?  
These questions and preliminary data led to the hypothesis that the signaling 
events resulting from host cell adhesion of B. infantis induce gene expression 
changes associated with longevity and promote cell survival. Describing the 
molecular mechanism that results in health benefits for the host is required for 
the identification of other potential probiotic bacteria as well as the application of 
probiotic microbes as medical treatments for specific diseases (117). Recent 
clinical studies report benefit for treatment of irritable bowel syndrome using 
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B. infantis (152). As B. infantis is not a pathogen, where nearly all of the 
knowledge related to host signaling related to host-microbe interaction lies, there 
is little to no molecular mechanistic explanation for the reported benefits.  
 This study examined the hypothesis by characterizing the host signal 
transduction networks induced by adhesion of a known probiotic bacterium, 
B. infantis, to gut epithelial cells in vitro. By determining the host gene expression 
a potential pathway was determined and subsequently validated using western 
blot analysis for protein level increases and phosphorylation changes that lead to 
activation of specific transduction pathways to prove the molecular mechanism 
leading to decreased cytotoxicity.
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CHAPTER II 
LITERATURE REVIEW 
 
 
Bacterial Adhesion Mechanisms 
 The varied means that bacteria use to adhere to surfaces in environmental 
niches is as diverse as the bacteria themselves. Adhesion to human cells is the 
initial necessary step for bacteria to colonize, bind cellular molecules, and leads 
to invasion. As such the mechanisms of pathogenesis has been examined in 
detail (11, 35, 43). 
 The structures described in detail that pathogenic bacteria use for 
adherence to host cell membranes consist of fimbriae or pili (113), bacterial 
lectins (91), flagella (107), and lipopolysaccharides (LPS) (76) (TABLE 1). In all 
cases these bacterial structures are defined to bind sugars or complex sugars on 
the host. These adherence factors along with all other proteins that are specific 
to bacterial adhesion to some extracellular surface are collectively known as 
adhesins (77). Specifically, these attachment factors are necessary to help the 
bacteria overcome the net negative charge that exists on both the host cell and 
the microbial cell (113). Unfortunately, the proteins that are used to mediate other 
interactions beyond sugars are yet to be fully described. 
 Fimbriae or pili are hair-like structures that extend out from the surface of 
bacteria. Often found along the edges or tips of the pili are specific proteins that 
bind to specific host targets (35). Fimbriae are found in both Gram-positive and 
  8 
 TABLE 1. Classes of adhesins used by pathogenic bacteria.  
Adhesin Structure Bacterial Function Host Target 
Fimbriae (pili) 
Short hair-like structures, 
often hundreds cover 
entire surface of organism, 
0.5-10 !M in length 
Transfer genetic material and 
or proteins during conjugation 
ECM components, surface 
receptors, use glycan (mannose) 
to bind 
Bacterial 
Lectins 
Protein or protein 
complexes, located on 
bacterial surface, or at 
ends of pili and flagella, 
None known; only observed in 
specific protein-saccharide 
interactions; thought to bind 
oligosaccharides during 
adhesion to surfaces 
Saccharides-found on glycolipids, 
glycoproteins, or other host 
structures. Often specific for 
mannose 
Flagella 
Long, flexible hair-like 
structures, can be 
localized to one region, 
few in number, up to 
15 !M long  
Provide motility Surface receptors, bacterially 
excreted proteins, ECM 
components, use glycan 
(mannose) to bind 
LPS 
Lipid-A base, saccharide 
core with O-antigen 
terminus. Typically 
anchored in cell surface 
but can be excreted 
Component of Gram-negative 
cell wall. 
TLR4 & 5, host lectins 
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Gram-negative bacteria, and are separated into different categories or types 
based on how the structures are assembled (113). For gram-positive organisms 
there are two main classifications - rod-like and flexible (46, 113). In Gram-
negative bacteria five types of pili are found: 1) chaperone–usher pili, 2) curli, 
3) Type IV pili, 4) Type III secretion needle (part of the Type III secretion system 
that delivers effector molecules to invade the host), and 5) Type IV secretion pili. 
As noted in the name of some of the pili classes, these structures are not only 
used for adhesion, but also for the secretion of proteins and genetic material 
during conjugation, as well as motility (46, 70). The adhesion of Salmonella sv 
Typhimurium to specific cell types when expressing specific fimbriae is a 
prototypical example of how fimbrial structures allow for specific binding between 
host and microbe that are tissue specific and regulated by the local environment 
(9). In Salmonella infections a fimbrial lectin, SEF17, specifically binds to host 
epithelial fibronectin (an ECM glycoprotein) allowing for the bacteria to adhere 
and initiate the infection process with the host cell via subsequent endocytosis 
mechanisms (80, 82, 105, 118).  
 Lectins are proteins that specifically bind saccharides (90). Specificity is 
sufficiently high so as to discriminate D-glucose-binding and D-mannose, the C-2 
epimer of glucose (39). Nearly all organisms express proteins with lectin activity 
(91, 93) and are involved in host-host, host-virus, and host-microbe interactions 
(91). Lectins are often found as integral parts of other bacterial adhesins, such as 
pili, and may account for the adhesive properties of those structures (91). Lectins 
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are often large multi-domain protein complexes but the actual carbohydrate 
binding activity is usually observed in a single protein sub-unit or domain within 
the larger molecular complex (91). The most studied case of lectin mediated 
host-microbe interactions is that of host mannose, galabiose, and N-
acetylglucosamine binding by lectins produced by E. coli (107, 147). E. coli P-
type fimbriae specifically bind galabiose found in human urinary tract tissue; their 
S-type fimbriae bind mannose in human neural tissue, and E. coli K99 fimbriae 
bind N-acetylglucosamine found in intestinal cells (147).  
 Flagella are long, flexible protein structures that are responsible for 
bacterial motility. They are also implicated, as in the case of fimbriae, to display 
lectin activity, which account for their role in mediating microbial adhesion (35). 
Enterotoxigenic E. coli flagella and its adhesion to host cells is the most studied 
model with respect to flagellar-mediated adhesion to the gut. In this model, the 
bacterium secretes a protein, EtpA, which is bound at the end of the flagella 
filament. The flagellar complex bound by EtpA is presented to host that leads to 
adhesion between host and microbe (124). Flagellin, the monomeric constituent 
of bacterial flagella, has long been known to induce an inflammatory response 
via the binding of the host immune receptor TLR5 (51). Due to the fact that 
flagella are used primarily for motility and that the mammalian immune system 
has ample receptors specific to bacterial flagellin, initially the thought that flagella 
also mediated adhesion was somewhat controversial; in that light that a system 
that evolved two separate mechanisms for adhesion and motility would seem 
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beneficial (43, 98). In support to dual systems, Salmonella spp. secrete 
flagellin to specifically elicit an inflammatory response and thereby recruit the 
dendritic cells, the cell that contains the Salmonella specifically target (15). It is 
no longer in question that flagella mediate glycan-linked adhesion in eukaryotes 
(107, 119). Lipopolysaccharides (LPS, aka endotoxin) mediate adhesion 
between bacteria and host cells using Toll-Like Receptors (76, 154). LPS is a 
component of Gram-negative bacterial cell membrane and also acts as a toxin 
when independent of the bacterial cell (115). LPS (Fig. 1) consist of a lipid A 
base, which largely contributes to the toxic nature of this molecule, a saccharide 
core and an O-antigen terminus (146). LPS elicits a rapid and sever inflammatory 
response in healthy mammals, which is initiated by a chemokine signaling 
cascade initiated by TLR4, which specifically binds LPS during the infection 
process (154).  
 
 
FIG. 1. Schematic representation of LPS. The lipid base, shown as orange lines, 
is often associated with the bacterial cell membrane with the O-antigen, shown 
as blue hexagons, pointed away from the bacterial cell.  The saccharide core, 
shown in red, is often composed of oligosaccharides such as heptose. 
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 Bacteria evolved many ways to adhere to host cells. Definition of 
specific molecules involved in the association and the signal transduction beyond 
sugars and glycans is lacking. This area is growing due to the need for new 
antibiotics and emergence of multi-drug resistant strains in gut pathogens, 
especially Salmonella (19). However, an extensive amount of work is done to 
define the host response to bacterial attachment beyond the use of glycosylation 
or polysaccharides.  
 It should be noted that B. infanits is non-motile (23) or produce LPS.  
Without these mechanism commonly used by other bacteria to modify host cell 
signaling, the question as to how B. infantis modifies host cell signaling remains.  
 
Microbes and Host Cell Signaling 
 Successful microorganisms respond to external stimuli by producing a 
reaction that results in an increased chance of survival, which leads to adaptation 
and evolution of specific responses due to multiple environments and conditions. 
Multicellular organisms face an extra level of complexity in responding to external 
stimuli because it requires that individual cells communicate with the other cells 
at distant locations to produce a coordinated response. Additionally, multiple cell 
types within the organism produce and respond to many signals simultaneously. 
Transmission of the environmental stimulus to the interior of the cell for 
communication is known as cell signaling or signal transduction. The 
mechanisms of eukaryotic cell signaling have evolved over time into elegant and 
complex networks, with multiple levels of sensitivity, specificity, and regulation. 
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Despite the diverse means of signal transduction that have evolved there are 
some common themes that are used within a network to channel chemical 
signals into cellular responses. 
 There are two main levels of cell signaling - external stimuli mediated by 
ligands binding cellular receptors to propagate a signal into the cell and 
intercellular communication, which begins with production of molecules that 
interact with other cells. These are key to rapid changes in individual cells to 
encompass the entire multicellular organism. Communication occurs when a 
signal is propagated through the network to the appropriate target molecules so 
that a response can be mounted by the cell (110). Once transduced inside the 
membrane, signal transduction is further perpetuated by the use of several 
strategies that include modification of signaling molecules with sugars, 
phosphates, fatty acids, and additional carbon group modification (e.g. 
methylation, acetylation). An example of this type of communication (Fig. 2) is the 
activation of G-protein coupled receptors (GPCR). Often this interaction is a 
combination of a non-specific adhesion factor that brings the organism close to 
the cell that is followed by a more specific protein/cell interaction. Viruses use 
this strategy to gain entry into host cells (127). In some cases glycolipids (e.g. 
gangliosides) are the non-specific binding partner that leads GPCR activation 
(99). Another, example is where an enzyme, phospholipase C - a known 
bacteria-associated virulence factor, directly activates and transduces virulence 
via membrane GPCRs (24). Subsequently, this lipase cleaves PIP3 into two 
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additional messenger molecules, IP3 and DAG, both of which cause a series 
of additional signaling changes in the cell that lead to transcriptional changes 
(20). 
 
 
FIG. 2. GPCR signaling pathway involving phospholipase C. GPCRs activate 
phospholipase C (PLC), which initiates signaling cascades leading to 
transcriptional changes and virulence with bacterial adhesion. 
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 This is the most prototypical GPCR signaling pathway. In this manner an 
external stimulus is integrated and results in a signal being perpetuated inside a 
cell to cause a specific response attributed to a specific biological event at the 
cellular membrane.  
 The other main level of signaling occurs between cells. Intercellular 
signaling can result from the interaction of surface-bound receptors with a  
product from another cell type. For example, chemokines and cytokines are 
immune-modulating molecules produced by immune cells to recruit additional 
cells to a specific location. These molecules are bound by receptors at the 
surface of migrating leukocytes that causes these cells to take on new activities 
or migrate to a new location via concentration gradients (153). Other examples 
include signaling molecules that bind surface receptors, like GPCRs, to modify 
cellular transcription (44), or cross the cellular membrane to receptors that lie 
within a cell such as nitric oxide (30). 
 Intercellular signaling can take place over large distances. Many different 
types of signaling molecules ranging from small soluble chemicals to large 
proteins (e.g. hormones) or fatty acids travel between cells and organs to induce 
changes in the organism. These molecules include gases like nitric oxide, 
peptides such as insulin (74), small molecules such as Ca2+ ions (74), fatty acids, 
and fatty acid derivatives, such as prostaglandins (7), along with many other 
examples.  
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 Another example is cell-to-cell communication mediated by contact and 
adhesion via proteins expressed on cell surfaces that initiate signals in 
neighboring cells (Fig. 3). Signaling molecules that are bound to cell surfaces are 
effective at perpetuating a signal when that cell comes in contact with another 
cell that is displaying the appropriate receptor.   
 The different properties of each signaling molecule allow for greater 
diversity of signaling channels, receptor specificity and sensitivity, as well as 
means of regulation. The combination of all of these factors allow for a near 
limitless variety of signals that a cell can produce and process. 
 For each signaling molecule there is a receptor that can detect the 
presence of the signaling molecule and in some manner perpetuate the signal. 
My hypothesis is that B. infantis is acting as a signaling molecule setting off an 
undefined signaling cascade leading to improved host health. As Bifidobacterium 
spp. do not invade host cells (103), yet do induce changes in host cells we will 
examine the largest classes of cell surface receptors (Fig. 3) that are ion 
channel-linked receptors, G-protein coupled receptors, and enzyme linked  
receptors (1). These receptors are of interest because it has been demonstrated 
that bacteria can act as signaling molecules, binding the surface of host cells and 
initiating signaling cascades and they are co-receptors for gangliosides (66, 132).  
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FIG. 3. Eukaryotic cell signaling induced by channels and G-proteins. Panel 1 depicts Intercellular signals are often 
internalized using these common surface receptors. Example A depicts an ion channel-linked surface receptor 
responding to ligand binding by opening ion specific channels that allows ions to move into or out of a cell (2). 
Example B demonstrates a G-protein-linked surface receptors upon ligand binding activate the associated G-
protein. Inactive G-proteins bind GDP. Upon activation the GDP is displaced by GTP, allowing the G-protein to 
activate its target enzymes (111). Example C shows an enzyme-linked surface receptor that bind a ligand to 
catalyze a reaction that perpetuates an intracellular signal (131). Panel 2 is an example of intercellular signaling 
pathway. 
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Extra Cellular Matrix, Gangliosides, and Host Signaling 
 Microbial binding structures have evolved to bind to a variety of host 
structures proteins in the extracellular matrix (ECM) (31, 54) and others as 
previously mentioned (14, 39, 64, 71, 91, 121). These receptors are often found 
as components of or linked to the host cell signaling machinery, and as such 
bacteria, and bacterial secreted components, become signaling molecules. It 
then becomes of great interest what the host signaling response is to the 
adhesion of different bacterial species. With the intense focus on the sugar-
binding molecules, exploration and definition of the binding partners between the 
bacterium and the host for the other class of molecules is largely unexplored. 
 As a common site of bacterial adhesion and of special relevance to this 
work is the mammalian ECM (123). The ECM is a structure of proteins and 
polysaccharide macromolecules that are largely responsible for cell and tissue 
differentiation, migration, repair, adhesion and even wound healing (59). The 
overall form and function of tissues is largely a result of cellular ECM interactions 
(49, 108). Major constituents of the ECM are glycosaminoglycans (largely found 
attached to proteins resulting in the formation of proteoglycans (57)), and fibrous 
proteins including collagen (69), elastin, fibronectin, laminin, and vitronectin 
(136), all of which are highly glycosylated (147). This results in a myriad of 
niches, motifs, and structures that are ideal for bacterial adhesion to occur via 
fimbriae or other proteins on the bacterial surface (11). This matrix also plays a 
key role in processing cellular communication and tissue structure. The ECM 
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binds cells to the basement membrane via integrins in the membrane, which is 
also involved in cell shape with the intimate association with actin in the 
cytoskeleton (128). 
Integrins are signaling proteins that are responsible for binding and 
responding to stimuli originating in the ECM, and can perpetuate signals between 
cells (17, 52, 63) that enable the ECM to facilitate eukaryotic cell signaling events 
between the epithelium and the other underlying tissues (128). Some pathogens, 
such as Shigella flexneri, some E. coli strains, and some Salmonella serovars 
bind integrins to hijack the host signaling mechanisms that perpetuate invasion 
and subsequent systemic infection (73). The exact binding domain (glycan or 
protein) is not yet defined.  
Gangliosides are key components of the host plasma membrane that play 
integral roles in signaling (55, 97, 99) and are constructed of a ceramide core 
with an attached oligosaccharide (together called a glycosphingolipid) to which 
one or more sialic acid is bound (78). These compounds are found in high 
concentration in lipid rafts, where interestingly GPCRs are also found to be 
concentrated. Maudsley et al. (97) found that when GPCRs are located in lipid 
rafts they initiate cell signaling networks that lead to increased cell proliferation. 
In other cases in the same cell GPCRs outside of lipid rafts initiate signaling 
networks that lead to decreased proliferation. Further links between GPCR 
signaling and gangliosides was described by Gouni-Berthold et al. (55) whose 
work showed that gangliosides initiated signaling events via GPCR pathways in 
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smooth muscle cells. McNamara et al. (99) described how Pseudomonas 
aeruginosa flagella bind gangliosides in vitro. Close association of gangliosides 
with host cell signaling events, specifically via GPCRs, and the known binding of 
gangliosides by B. infantis (31, 32) recently demonstrated by Desai et al. point 
one to question. Does B. infantis initiate signaling cascades via GPCRs following 
adhesion of gangliosides? 
 Bacteria modulate host cell signaling during adhesion and invasion (66, 
73, 132). Yersinia infections are a classic example of how a pathogenic microbe 
affects the signaling mechanisms of a host cell. As reviewed by Isberg et al. (66), 
a protein expressed on the surface of Yersinia spp. called invasin is able to bind 
multiple integrins that are expressed on the surface of microfold cells (M-cells) 
found in Peyer’s patches. These specialized cells are responsible for antigen 
sampling in the lumen of the gut and are considered to be the front line of the 
mucosal immune system (67). Integrins, the molecular binding partner of invasin, 
are responsible not only for cellular adhesion but also initiating intracellular 
signaling cascades (17, 52, 63). By specifically binding integrins found on M-cells 
Yersinia spp. induce M-cells to phagocytose the bound bacterium by 
manipulating the host signaling mechanisms. Subsequently, the internalized 
bacteria are hidden within a membrane bound compartment inside the host cell 
preventing the organism’s immune system from eliciting a response to eradicate 
or clear the infection.  
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 Another example of cell signaling manipulation by a pathogen is Listeria 
monocytogenes gut infections. Similar to many gut pathogens, 
L. monocytogenes induces phagocytosis by manipulating the host signaling 
mechanisms for the cytoskeleton. This organism uses internalin A and B, which 
interacts with E-cadherin on the host membrane to induce cytoskeletal changes 
that enables endocytosis and access to the cytosol (132). In the host, E-cadherin 
is a key protein that mediates epithelial cell adhesion and tight gap junction 
maintenance, but also plays a role in intracellular signaling via the E-
cadherin/PKC signaling pathway (79, 87, 145). L. monocytogenes uses this 
strategy along with actin movement to move laterally between cells as a method 
to evade the immune response so the infection can spread throughout the host. 
This strategy is also used to move between cell types. For example, this is how 
L. monocytogenes moves from the gut into circulation and then to cross the 
blood-brain barrier to cause a secondary infection from the initial invasion site in 
the gut epithelium (132). 
 Commensal bacteria also modulate the host immune system to allow the 
host to tolerate their presence (5). Recent findings linked host cell signaling 
caused by the presence of commensal bacterial LPS, which is usually only found 
on pathogens, and the subsequent decrease in the amount of pro-inflammatory 
mediators in vitro (36). Furthermore, factors produced by the host following the 
introduction of commensal bacteria initiate differential gene expression in the 
host with respect to cell surface receptors that are specific to bacterial surface 
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molecules, without which the cells ability to illicit an inflammatory response is 
greatly reduced (16). In effect, the commensal microbes prime the immune 
system. Additionally, Bacteroides thetaiotaomicron reduces inflammatory 
cytokine production by inducing nuclear exportation of RelA via a PPAR-!-
dependant pathway (72).  
 As previously mentioned, the vast majority of knowledge with respect to 
host microbe interactions is limited to the host-pathogen and host-commensal 
relationships (Fig. 3). In a recent review Marteau et al. (95) described many 
studies that demonstrated the results of the presence of probiotic microbes on 
host health, but noted that the field lacks specific information about the pathways 
from which those effects were derived. Even studies that have specifically 
addressed an individual probiotic microbe and the effect that specific microbe 
has on host health, have not demonstrated the specific mechanism of action, 
with respect to host signaling cascade or host-microbe binding partners (89). 
One study using B. infantis showed increased phosphorylation of MAPK proteins, 
but not the signaling route that led to increased phosphorylation or what 
phenotype the modified phosphorylation led to in the cell (40). Additional 
information to define the specific events that occur immediately following 
probiotic adhesion and the host signaling cascade that is triggered would provide 
critical information to provide a sound physiological role for these organisms. 
Furthermore this will aid in identification of new probiotic strains, as well as the 
implementation of probiotics to treat specific human ailments. 
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Bifidobacteria and Other Probiotics 
 What today are recognized as organisms from the genus Bifidobacterium 
were first described by Tissier in 1899-1900 and called Lactobacillus bifidus 
(112). The name was largely given due to frequent observation of bifurcating, 
gram-positive rod morphology observed in microscopy. Subsequent studies 
showed that this bacterium dominated the gut microbiota of breast fed infants 
(41, 151). Differences in Bifidobacterium populations depending on the food 
source of the infant were observed and studied in the early 20th century starting 
with Tissier, and continue to this day (75). Most recently the genome of 
B. infantis 15697 revealed genes that allow this bacteria to digest human milk 
oligosaccharides that remain indigestible to humans alone that give bifidobacteria 
a nutrient-based selective advantage in breast-fed infants (133).  
 Probiotics are bacterial organisms that when consumed provide some 
benefit to the host other than the basic nutrition gained from their consumption 
(47). The term “probiotic” was most likely first used by Kollath in 1953 to describe 
anything that restored the health of patients suffering from malnutrition; however, 
direct association to bacteria came from Vergin slightly later (56). The idea that 
bacteria could have beneficial impacts on human health dates back to the Nobel 
Laureate, Ilya Ilyich Mechnikov, who later in his life recognized that by 
manipulations of the body’s microbiota by diet, the health of an individual could 
be influenced, which he quietly associated with benefit (148).  
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 Recent clinical trials assessing the ability of a B. infantis strain to 
remediate the symptoms of irritable bowel syndrome (IBS) revealed that indeed 
giving encapsulated B. infantis 35624 to women with IBS significantly reduced 
their symptoms versus a placebo (152). This result most certainly classifies 
B. infantis spp. as a probiotic organism. While the beneficial aspects of these 
bacteria are known, the mechanisms by which these benefits are gained remain 
unclear (Fig. 4).  
 Numerical dominance of B. infantis in the infant gut of breast fed babies is 
well known (41, 75, 151). This near complete occupation of host gut at such a 
critical time in the organism’s development strongly suggests an extended 
evolutionary history between the two organisms. If both organisms did not 
experience some positive influence towards their survival such a relationship 
would be selected against. This idea is further bolstered by the work of Sela et al. 
(133) showing that B. infantis contains genes that allow the bacteria to digest 
complex oligosaccharides found in human milk that are not able to be digested 
by human cells. While this could be the driving selective pressure that maintains 
this near symbiosis in infants, the mechanisms within the host that permit the 
bacterial presence, as well as the observations of improved health in adults, are 
not explained by Sela’s observations. 
 Competitive exclusion of bacterial pathogens is often cited as the 
mechanism by which adult hosts gain benefits, as studies with other probiotics 
have demonstrated (85). Other groups found that certain B. infantis species 
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secrete soluble antimicrobial compound(s) that lead to the death of bacterial 
pathogens in vitro (89). 
 
 
 
FIG. 4. Host colonization by pathogenic and probiotic bacteria. 
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While these observations may be contributing factors they completely ignore 
the most important step necessary for bacterial access to the gut surface for 
adhesion, colonization, and persistence. As previously described, bacteria can 
initiate signaling pathways and following adhesion to host cells elicit host 
signaling cascades that are ultimately responsible for the final host phenotype 
(66, 132). Recognizing the likely evolutionary history that should exist between 
host and microbe in the case of B. infantis one would expect to find specific 
receptors that are the molecular binding partners of the bacteria. Consequently, 
one can expect that adhesion of B. infantis will initiate a cell-signaling cascade 
within the host. 
 The prevailing theory is that B. infantis competitively excludes other 
bacteria from adhering thus hindering pathogenic infections (89). While this 
certainly may play a role in the health benefits it is unlikely to be the complete 
story, and does not account for the claimed systemic health benefits that the 
microbes impart to the host.  
 Recent work by Desai et al. (32) demonstrated that food-borne pathogens 
and B. infantis bound various components of the ECM (31), suggesting that B. 
infantis may initiate signaling via ECM binding. Considering the evolutionary 
association and clinical demonstration of B. infantis with the host, it is logical that 
adhesion of B. infantis to the host cell invokes the host cell to change. It is very 
likely that this is done using known signal transduction routes that initiate new 
phenotypes to provide very specific benefits to the host. The lack of knowledge 
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surrounding the molecular mechanisms waits to be explored and defined. 
Creating an experimental model that allows direct, hypothesis-driven queries of 
the cell signaling pathways activated by B. infantis adhesion will provide great 
insight into the underlying mechanisms of improved host health could be 
uncovered. This would be a step to provide insight into host health as a whole, as 
well as a model for uncovering similar information about other microbial/gut 
interactions beyond those defined by infectious disease models.  
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CHAPTER III 
MATERIALS AND METHODS 
 
Mammalian Cell culture  
Human colon colorectal adenocarcinoma Caco-2 cells (ATCC HTB-37) 
were grown in Dulbecco's modified Eagle's medium (DMEM) high glucose media 
with 2 mM L-glutamine and 1 mM sodium pyruvate, combined with %16.6 fetal 
bovine serum (FBS) by volume, 10 IU/ml Penicillin, 0.10 mg/ml Streptomycin and 
1X non-essential amino acids (EmbryoMax ES Cell Qualified MEM, 100X, 
Millipore, Billerica, MA) in accordance with ATCC (American Type Culture 
Collection, Manassas, VA) recommendations. Due to the fact that these cells 
were to be co-cultured with bacterial cells an additional buffer composed of 10 
mM 3-morpholinopropanesulfonic acid (MOPS), 15 mM HEPES, 10 mM N-
(Tris(hydroxymethyl)methyl)-2-aminoethanesulfonic acid (TES), 2 mM sodium 
phosphate was added to further buffer the media (pH 7.2) (37). Incubation 
conditions were 37°C at 5% CO2 in a humidified atmosphere. Cells were given 
fresh media according to need, but approximately every 2 d. Cells were grown in 
BD Falcon T-75 0.2 µm vented-cap, canted-neck flasks (Becton, Dickinson and 
Company, Franklin Lakes, NJ). During periods of extended culturing Caco-2 cells 
differentiate and exhibit a phenotype similar to that of intestinal epithelial cells. 
Time until differentiation is 16 d following confluence (126); to more closely mimic 
the conditions found in the human gut all adherence and gene expression assays 
will be done at day 21-22 post inoculation to allow for complete differentiation. 
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Final feedings 24 hr prior to the addition of bacteria were done with media 
lacking antibiotics and serum. This serum starvation was done to promote cell 
cycle synchronicity. 
 
Bacterial Culture   
B. infantis (ATCC 15697) was sub-cultured twice from freezer stocks to 
late stationary phase (36 hours) in deMan, Rogosa and Sharpe broth (MRS) 
containing an additional 0.5 % cysteine (Difco, Detroit, MI) at 37ºC using 
anaerobic conditions. The cells were centrifuged at a 5,500 X g for 1 min. to 
create a loose cell pellet after which the pellet was washed once with PBS and 
resuspended in mammalian cell culture media without serum (see above) at the 
required density of 10 X 106 CFU/ml (colony forming units). This cell suspension 
was used to interact with Caco-2 monolayers at a multiplicity of infection (MOI) of 
1000:1 (1000 bacterial cells per Caco-2 cell) (120), which was approximately 10 
ml of the afore mentioned cell suspension per T-75 flask. 
Salmonella ser. Typhimurium LT2 (ATCC 700720) was grown, from 
freezer stocks, in Nutrient Broth (Difco, Detroit, MI) at 37ºC shaking at 220 rpm. 
After the first growth phase the cells were collected by centrifugation and 
transferred into Nutrient Broth for an additional 24 hr. The third transfer, used to 
perform the experiments in this study, was done in cell culture media lacking 
serum and antibiotics. After the third transfer, the organisms were grown for 
approximately 16 h (stationary phase). These cells were then collected by 
centrifugation and re-suspended in fresh cell culture media lacking serum and 
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antibiotics at the required density of 1 X 106 CFU/ml). These cells were 
subsequently used to conduct adhesion studies with Caco-2 cells at an MOI of 
1000:1 (bacterial cell:host cell) in a final volume of 10 ml/flask. 
 
Ganglioside Binding and Real Time-PCR 
Gangliosides were purified from bovine buttermilk as described by Walsh 
and Nam (149). Briefly, the purification of gangliosides included ultrafiltration of 
fresh buttermilk (Gossner Foods, Logan, UT) with a 1 kDa membrane to remove 
the lactose followed by an organic extraction with chloroform:methanol:water 
(40:80:30). The purified gangliosides (6 !g) were used for immobilization with 
100 g of 3 mm solid glass beads (Fisher Scientific, St. Louis, MO), which 
produced bioactive beads (gangliobeads) with a mixture of gangliosides on the 
surface as described by Walsh and Nam (149). 
B. infantis was grown to exponential phase in media and conditions as 
described above. Bacterial cells were washed twice in saline and diluted to an 
OD600 of 0.2 in saline. This suspension (2 ml) was exposed to 10 beads for 10 
min at 25˚C with agitation and washed three times with 50 mM Tris Cl (pH 7.2) 
for 5 min each. The presence or absence of B. infantis on the beads was 
quantified by RT-PCR (real-time-PCR) using universal bacterial 16S primers 
(IDT, Coralville, IA)  
Following interaction with B. infantis, beads were washed in saline and 
added to 100 !l of distilled water and boiled 10 min to lyse bound bacterial cells. 
An aliquot of the boiled sample (12.5 !l) was used for RT-PCR with universal 
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bacterial 16S primers (IDT, Coralville, IA). Forward primer sequence was 5’-
AGAGTTTGATCCTGGCTCAG-3’ and reverse primer sequence was 5’-
ACGGCTACCTTGTTACGACTT-3’. The DyNAmo HS SYBR Green qPCR Kit 
(MJ Research, Waltham, MA) was used as per the manufacturer’s 
recommendations in combination with a DNA Engine Opticon 2 thermal cycler 
(MJ Research). The thermal cycler was run for 50 cycles of 15 sec at 95˚C 
(melting), 30 sec at 60˚C (annealing) and 45 sec at 72˚C (extension and plate 
read). The threshold cycle number, C(t), was reported using the Opticon Monitor 
analysis software (Ver 2.02, MJ Research). Appropriate negative controls to 
probe for nonspecific binding (using 3 mm glass beads instead of gangliobeads) 
and sterility of the beads and buffers (using gangliobeads with saline instead of 
bacterial suspension) were also performed along with the test samples. The 
experiment was done in three biological replicates with RT-PCR in duplicates.  
 
RT-PCR Data Analysis for Ganglioside Binding 
A standard curve correlating log CFU with C(t) value was generated, by 
performing RT-PCR on samples of DNA extracted from log 5, 6,7 and 8 CFU/mL. 
Trend line analysis (performed in Microsoft Excel 2008 V12.0, Redland, WA) of 
the resulting C(t) values yielded the Equation (1):  
C(t) = 2.624(bacterial population) - 40.77  [r2=0.97] (Equation 1) 
C(t) values obtained from RT-PCR of the ganglioside-containing beads 
and glass beads and converted into bacterial population amounts using the 
equation generated from the standard curve. These values were then tested for 
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significance using an unpaired Student’s t-test to compare the number of 
B. infantis adhered to the beads vs. the glass bead control. Statistical analysis 
was done using Prism 5.0 (GraphPad Software, San Diego, CA) 
 
Host Gene Expression 
Human Caco-2 cells were grown to confluence and allowed to differentiate 
following previously established protocols. Bacterial cultures were added at a 
MOI of 1000:1. At 30 min, 60 min and 120 min, respectively. Subsequently, 10 ml 
of Trizol LS (25), (Invitrogen, Carlsbad, CA) was added to the cell culture flask 
and incubated at 37°C for 15 min. Caco-2 cells were more thoroughly lysed by 
repeated pipetting of the Trizol LS followed by transfer to 15 ml conical and 
stored at -70°C until further RNA purification was done.  
 Trizol LS containing samples were freeze thawed three times (liquid 
N2/60ºC) to further lyse host cells. The samples were then centrifuged at 8,000 
rpm for 5 min to pellet cellular debris as well as bacteria that remain intact 
following Trizol LS treatment. The supernatant contained Caco-2 RNA. RNA 
isolation proceeded as per Trizol LS manufactures’ protocol. RNA quantity was 
determined using a NanoDrop 1000 spectrophotometer (Thermo Fisher Scientific 
Inc. Waltham, MA). Sample quality was assessed using the Bio-Rad Experion 
RNA StdSens analysis kit with their Experion automated electrophoresis station 
(Bio-Rad Laboratories, Hercules, CA). 
Two biological replicate RNA samples were subjected to Affymetrix 
GeneChip One-Cycle Eukaryotic Target Labeling procedure according to 
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manufactures' recommendations. Briefly, sample RNA is reverse transcribed 
using T7 oligo (14) primer to create cDNA. This cDNA is again reverse 
transcribed using a T7 RNA polymerase, biotinylated nucleotide analogs and 
ribonucleotides to create labeled cRNA. These cRNAs were hybridized to a 
Human U133+2.0 Affymetrix GeneChip and further processed by the Genomics 
Core facilities at the Center for Integrated BioSystems Genomics Core (Utah 
State University). The arrays were processed using a GeneChip fluidics station 
450, a GeneChip hybridization oven 640 and scanned with a GeneChip Scanner 
3000 implementing Affymetrixs’ GeneChip operating software (GCOS).  
 
Statistical Analysis of Gene Expression Data 
Using BioConductor (50) via a web based interface (http://cib-
xcluster.biotec.usu.edu/BioC.html) the raw hybridization intensities from the 
arrays were pre-processed using the robust multi-array average (RMA) method 
(65). Following pre-processing the data were analyzed using the SAM 
(significance analysis of microarrays) plug-in for Microsoft Excel (144) to identify 
genes that were significantly differentially expressed with a false discovery rate 
(FDR) of less than 5%. The model used was a two-class unpaired time course, 
using the default settings. These significant genes were uploaded to Ingenuity 
Pathway Analysis (IPA) (116), (Ingenuity Systems Inc., Redwood City, CA) for 
pathway reconstruction and visualization. 
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Pathway Analysis Using Ingenuity Pathway Analysis 
A core analysis using IPA (116) was done using the log2 ratios of 
treatments to control for the significant genes identified using SAM. Using the 
IPA library, each of the canonical signaling pathways was examined to determine 
what pathways contained genes from our dataset. The data set was overlaid onto 
the canonical pathways using the “overlay” feature. When protein complexes or 
groups of proteins were represented in a pathway, and found to contain a 
significantly changing gene, the “show members/membership” feature was used 
to identify what specific gene identified by the gene expression analysis was 
accounting for significance and what role that gene played in the complex or 
protein group. To create pathways for better visualization and for placement in 
the text of this document, relevant sections of canonical pathways were selected 
and edited in the “pathway designer” portal. All connections between proteins, 
small molecules, chemical reactions, etc., are linked to peer reviewed studies 
held in the Ingenuity database (use of this feature is available upon subscription 
only). Critical links relevant to this study have been cited in this work. 
 
Gene Ontology Analysis 
 The list of significant genes (log2 ratio) were uploaded to GOEAST (157), 
a web based gene enrichment testing tool based on the gene ontology 
consortium (4) classification scheme, to determine what groups of molecular 
functions, biological processes or cellular components had higher than expected 
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significantly differentially expressed genes. Default settings were used with the 
exception of the significant level of enrichment, which was set at q" 0.01. 
  
Protein Sample Collection 
Co-cultures from which proteins were sampled were created in the exact 
same conditions as previously described for the gene expression samples 
through the incubation periods with the bacteria. Following interaction with the 
respective bacterial treatment, media in flasks was removed and cell layers were 
washed with PBS to remove non-adherent bacteria and cellular debris. The co-
cultures were scraped from the flask and re-suspended in 1 mL cell lysis cocktail 
modified from Pawson et al. (109) in 30 mM HEPES (pH 7.4) containing 1 mM 
EDTA, 50 mM Sodium pyrophosphate, 100 mM sodium fluoride, 10 mM 
orthovanadate, and Roche protease inhibitor cocktail tablet (added fresh, per 
manufactures recommendations - 1 tablet per 50mL buffer) (Roche Indianapolis, 
IN). The cell suspension and lysis buffer were then added to 2 mL screw cap 
tubes with 0.5 g of 0.1 mm glass beads and bead beat in a BioSpec mini-bead 
beater (BioSpec Products, Bartlesville, OK) for 30 seconds. The samples were 
stored at -80°C for further analysis. 
 
Protein Concentration Determination 
Protein concentrations were determined using the Bio-Rad DC Protein 
Assay kit according to the manufactures’ protocol, with the exception of using 
Bovine Serum Albumin (BSA; catalog number 15561-020) from Invitrogen in 
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place of the provided protein standard. The assay was performed in a Nunc 
F96 MicroWell plate using a Molecular Devices SpectraMax Plus 384 plate 
reader. Analysis of the readings was done using Molecular Devices SoftMax Pro 
software (version 3.1.2). All standard and sample concentrations were quantified 
in duplicate. 
 
Cytotoxicity Assay 
To assess the impact of the presence of B. infantis to the viability of the 
host model, a cytotoxicity assay was performed. Caco-2 cells and bacterial cells 
were all cultured as previously described, except that Caco-2 cells were cultured 
in 12-well plates instead of flasks. Bacteria were added to the differentiated 
Caco-2 monolayers according to the scheme presented in Fig. 4. Following the 
120 min. incubation, monolayers with microbes were washed with PBS to 
remove non-adherent bacteria, and treated with 1X porcine trypsin for 5-7 min. 
Adding fresh cell culture media containing serum and buffer without antibiotics 
stopped trypsinization. This suspension was divided in half, and used for analysis 
of total cell count and viable cell count using a NucleoCounter (ChemoMetec A/S 
Denmark) according to the manufacture recommendations. Briefly, for total cell 
counts (TC), 100 µl of lysis buffer followed by 100 µl of fixing buffer to 100 µl of 
cell suspensions and briefly mixed using a vortex. For suspensions to assay 
viable cell count (VC) 100 µl of suspension was combined with 200 µl PBS and 
mixed. Each treatment was measured in using two biological replications.  
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Statistical Analysis of Cytotoxicity Assay Data 
 Cell counts obtained in the cytotoxicity assay were converted into percent 
survival using Equation 2:  
 
Percent viable cells = ((TC-VC)/(TC))*100  (Equation 2) 
 
TC = total cell count, VC = viable cell count. Statistical analysis was done using 
JMP V7.0 (SAS Institute Inc., Cary, NC). A Tukey’s post hoc analysis was done 
to determine the statistical differences between the levels within a treatment.  
 
Western Blot Analysis 
  The sample loading dye and preparation buffer consisted of 37.5 mM Tris 
(pH 6.8) containing 137.5 mM glycerol, 73.75 mM SDS, 1.15 M "-
mercaptoethanol to reduce disulfide bonds in the proteins, and a few grains of 
brilliant blue dye to act as a marker of sample migration. Protein samples at a 
concentration of 50 mg/mL were added to the sample dye and preparation buffer 
and denatured by boiling for 5 min. Protein samples were then loaded in 10% 
Tris-HCl (pH 6.8) polyacrylimide gels and run in the Bio-Rad Mini-PROTEAN 3 
cell using a buffer containing 25 mM Tris base (pH 10.7), 192 mM glycine and 
3.5 mM SDS (pH 8.3) at 110 V until the dye front had reached the bottom of the 
gel. The standard used was MagicMark XP western protein standard from 
Invitrogen. The separated proteins were transferred to a PVDF membrane 
(Thermo Scientific product number 88518) using a transfer buffer consisting of 25 
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mM Tris base (pH 10.7) containing 200 mM glycine and 20% (v/v) methanol in 
water. The transfer was done using 100 V for 70 min. After transfer the blot was 
probed for the presence of specific proteins corresponding to the potential 
signaling pathway determined using the gene expression data using commercial 
antibodies (TABLE 2). Western blots were done using the Pierce Fast Western 
Blot Kit, according to the manufactures recommendations, with an additional 60 
min blocking step with 2% non-fat dry milk in 20 mM Tris base (pH 10.7), 0.5 M 
NaCl (TBS), immediately before adding the primary antibody solution.  
If cross-reactivity was present that interfered with band development using the 
rapid method the analysis was repeated using a classical method (137). The 
classical method used a membrane blocked with 2% non-fat dry milk (Wal-mart 
Stores Inc., Bentonville AR) in TBS buffer (pH 10.7) for 60 min. The blocking 
buffer was removed and the blot was washed with the primary antibody overnight 
at 4ºC. The primary antibody was re-suspended in a buffer containing 2% non-fat 
dry milk, 20 mM Tris base (pH 10.7), 0.5 M NaCl and 1 mM Tween 20 (TTBS 
buffer). Following overnight mixing the blot was washed 2X for 10 min with TTBS 
(pH 10.7) buffer without non-fat dry milk and the washes were discarded. The 
blot was incubated at room temperature with the secondary antibody solution for 
120 min. The secondary antibody solution contained suspended a secondary 
antibody, conjugated to horseradish peroxidase, in TTBS buffer (pH 10.7) with 
2% non-fat dry milk. 
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TABLE 2. Primary antibodies used in this study. All antibodies were purchased 
from Novus Biologicals (Littleton, CO) except "-actin, which was purchased from 
Sigma-Aldrich (St. Louis, MO). Antibodies targeted toward specific 
phosphorylation states of the proteins that correlate to active signaling states are 
designated as phospho- and the target’s known phosphorylation site.  
Antigen Species and Type Dilution or concentration used 
GPR20 Rabbit Polyclonal 2 µg/ml 
GPR161 Rabbit Polyclonal 2 µg/ml 
PYK2 Rabbit Polyclonal 1:500 
PYK2 phospho-Tyr402 Rabbit Polyclonal 1:1000 
PDK1 Rabbit Polyclonal 2 µg/ml 
PDK1 phospho-Ser241 Rabbit Polyclonal 2 µg/ml 
AKT1 Rabbit Polyclonal 1:2000 
AKT1 phospho-Thr308 Rabbit Monoclonal 1:10000 
AKT1 phospho-Ser473 Rabbit Monoclonal 1:10000 
TNFAIP3 (A20) Mouse Monoclonal 2 µg/ml 
BIRC3 (aka cIAP2)  Rabbit Polyclonal 1:2000 
SERPINB9 Mouse Polyclonal 1:500 
"-actin Mouse Monoclonal 1:10,000 
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Following mixing the antibody solution was discarded and the blot was washed 
5X for 10 min. in TTBS (pH 10.7) without non-fat dry milk. The blot was protein 
side up on plastic wrap, exposed to the western blotting detection reagent 
(Amersham ECL Plus) so as to cover the membrane completely, and incubated 
for 1 min. Subsequently, the blots were imaged using the chemiluminescent 
detection with a FujiFilm LAS-3000 imaging system V 2.0 (FujiFilm U.S.A. Inc, 
Valhalla, NY) on the highest setting for 5 min. Image files were analyzed using 
FujiFilm Multi Gauge software to detect the bands. To validate constant sample 
concentration, blots were stripped and re-probed for "-actin (26). Stripping was 
done in a solution containing 62.5 mM Tris base (pH 6.8) containing 69.5 mM 
SDS and 100 mM "-Mercaptoethanol, at 50ºC for 20 min. Stripped membranes 
were briefly washed in TBS (pH 10.7) without non-fat dry milk followed by sterile 
water for 5 min. The membranes were probed as previously described using the 
Pierce Fast Western protocol with the previously described additional blocking 
step. 
 
Adhesion Assay 
Caco-2 cells were cultured as described above and plated at a density of 
105 / cm2 in a 96 well plate. Following differentiation, media from the caco-2 cells 
was removed and the cells were incubated for one hour at 37°C (5% CO2) in 
50 !l of GPR161 or GPR20 antibody serially diluted in DMEM. After 1 h, 50 !l of 
bacterial suspension washed in PBS (pH 7.4) and resuspended in the DMEM at 
108 CFU/ml was added to the caco-2 cells for an MOI of 100:1 and incubated for 
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an additional hour. The non-adherent bacteria were removed via aspiration 
and the caco-2 cells were washed three times with 200 !l of 1X Tyrode’s buffer 
(140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 10 mM 
glucose, 10 mM sodium pyruvate (pH 7.4)). The caco-2 cells were exposed to 
50 !l of DNA extraction buffer (AEX Chemunex, France). The cells were 
incubated at 37°C for 15 minutes and then at 95°C for 15 min. The cell lysates 
were stored at -70°C.  
Quantitative PCR (qPCR) was used to quantify the number of adherent 
microbes to caco-2 cells. Primer pairs for the desired microbes and caco-2 
monolayer were designed using Primer-BLAST (125). Primers used to quantify 
B. infantis amplified the fructose-6-phosphate phosphoketolase gene 
(BLON_1722) (Forward-GAC AGA GCG TAA CCC AGC TC, Reverse- ACT ACC 
CCT GGC CTG AAC TT). Primers used to quantify Caco-2 cells amplified 
G3PDH gene (Forward-ACC ACA GTC CAT GCC ATC AC, Reverse- TCC ACC 
ACC CTG TTG CTG TA). qPCR was done using iQ SYBR Green qPCR mix (Bio 
rad, Hercules, CA) as per the manufacturer’s recommendations using a CFX-96 
Real-Time PCR detection system (Bio rad, Hercules, CA). Standard curves with 
known number of bacteria (determined by plate count) and know number of 
Caco-2 cells (determined by direct microscopic count) were generated (data not 
shown). Based on the standard curve the number of bacteria present per caco-2 
cell were determined. The results were plotted and error bars added to the plots 
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using the standard error of the mean of the 4 observations made per treatment 
class. 
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CHAPTER IV 
 
RESULTS .. 
 
 
While the current field of host/microbe relationships is quickly expanding, 
little is known about host/probiotic microbe relationship. At the same time use of 
probiotic bacteria in food products is increasing with increasingly broad and 
undefined health claims, most of which remain to be substantiated. In 
consideration of the use of B. infantis and it’s role in the infant gut this study was 
undertaken to determine the biological importance, molecular mechanisms and 
resulting cellular phenotype induced in vitro by the interaction between an human 
intestinal epithelial model and B. infantis. Using a systems biology approach, the 
resulting host reaction to B. infantis was characterized as well as the signals 
responsible for producing the host phenotype to test the hypothesis that B. 
infantis binds host GPCRs to induce new and beneficial activities. 
 
Epithelial Cytotoxicity  
 The cytotoxicity of gut epithelial cells was assayed to determine if host cell 
survival was impacted by adhesion of bacterial cells. Adhesion of B. infantis in 
vitro to gut epithelial cells significantly (p=0.006) increased the viable cell 
population. Unfortunately, addition of B. infantis simultaneously with Salmonella 
ser. Typhimurium did not rescue the host cell from death (Fig. 5). While 
B. infantis did not rescue Salmonella ser. Typhimurium–induced cytotoxicity, it 
did increase epithelial survival when presented alone. Consequently, the 
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remaining experiments focused on the interaction between the host and 
B. infantis to define mechanisms that increased survival of gut epithelial cells.  
 
 
FIG. 5. Gut epithelial cytotoxicity with addition of B. infantis (BI) and Salmonella 
er. Typhimurium (ST) after 60 min of co-incubation. The organisms were added 
at equal concentrations to the cell culture (1:1). Bars with the different letters 
indicate significantly difference responses (p<0.05).  
 
 
 Considering the decreased cytotoxicity imparted by B. infantis, the 
question becomes how does it impart this effect since this organism is not 
invasive, but does adhere to the epithelium? No receptors for B. infantis 
adhesion to host cells are known. Consequently, further experiments tested the 
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hypothesis that B. infantis bound specific host protein receptors that directly 
transduced intracellular signal transduction pathways to increase cell survival. 
Without knowledge of a specific receptor we used gene expression regulation 
during B. infantis adhesion to uncover the underlying molecular changes in the 
membrane proteins that are known to trigger or modify the cell cycle and survival.  
 To begin glycolipid adhesion was done based on the observations of 
Desai et al. (31), to establish a link between gangliosides and cell signaling as 
others have demonstrated with other microbes (3, 97, 99). Significantly (p<0.001) 
more B. infantis cells were bound to the beads by 10-fold as compared to the 
control. (Fig. 6A). Gangliosides are commonly used by viruses and bacteria to 
gain entry into the host cell (141, 142). Consequently, B. infantis was added to 
the gut epithelia to demonstrate that the microbes also bound GM1 (Fig. 6B) to 
determine if this interaction is relevant in vitro. Blocking the GM1 receptor on 
caco-2 cells significantly (p=0.05) reduced B. infantis adhesion by ~10%. 
Together, these observations indicate that this probiotic microbe uses 
gangliosides during adherance to gut cells. It is unlikely that this is the only 
receptor used. Subsequently, gene expression was used to discover additional 
receptor proteins that may be used by B. infantis to induce signal transduction 
pathways that are linked to decreased cytotoxicity. 
 Gangliosides are directly linked to host signal transduction through 
GPCRs (55, 97, 99).  
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FIG. 6. B. infantis binding of mixed gangliosides on glass beads. (panel A) and to 
caco-2 cells with before and after blocking GM1 with antibody (panel B). In each 
panel the treatments containing different letters indicate significant differences 
between the treatment and control (p"0.05). 
 
 The observations of B. infantis increasing cell longevity and binding 
gangliosides suggests that signaling is initiated following adhesion that results in 
increased cell survival initiated via GPRC signaling. Therefore, the hypothesis 
that B. infantis interacts with host GPCRs during adhesion to decrease 
cytotoxicity was tested.  
 
Gene Expression Changes During B. infantis Adhesion 
 Adhesion of B. infantis to intestinal epithelial cells initiated significant 
(q<0.05) regulation of 208 genes in caco-2 cells over 120 minutes co-incubation, 
which is ~0.4% of the entire the host genome (TABLE A.1). Gene regulation was 
almost entirely induction that increased over incubation time, indicating that the 
longer association of this non-invasive microbe initiated gene expression 
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changes that led to increasingly pervasive changes in the host cell. The 
phenotypic changes observed (Fig. 1) occurred within 120 min; therefore, the set 
of genes differentially expressed within the 210 genes mediated increased 
survival. B. infantis does not invade the host (103). Consequently, cellular 
changes must be transduced via membrane receptors during B. infantis 
adhesion.  
 Considering that the set of induced genes were involved in very diverse 
cellular processes and functions, gene ontology (4) (GO) enrichment analysis 
(21) was done to highlight the functional associations based on the significantly 
differentially expressed genes and reduced cytotoxicity. Significantly enriched 
categories were found in each of the three functional GO categories (TABLE 3). 
Significant GO nodes contained between 2 and 70 genes within each node. 
Based on the specific relationship to cell death, categories were selected for 
further investigation to define the molecular mechanism(s) that increased cell 
survival (Figs. B.1-B.3). 
 Critical examination of the GO enrichment analysis to specifically examined 
categories associated with decreased host cytotoxicity were identified . The only 
significant GO term in cellular component category was “nucleus,” GO:004066 
(p=3.24 x 10-5), representing the gene expression regulation via new transcription 
factors. Additional examination of genes from this category (Fig. 7) showed that 
genes were induced at 60 min. and they remained induced at 120 min. This 
temporal pattern was observed in other GO categories as well.
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TABLE 3. Significantly enriched GO categories during B. infantis association with intestinal epithelial cells in vitro. Some 
genes occur in multiple nodes, so the total number of genes in the analysis do not sum to 210. 
GO Category GO Term Annotation 
Number of 
molecules in 
category out of 210 p-value 
Cellular 
Component 0043066 nucleus 70 3.24 x 10-05 
     
Biological Process 0006350 transcription 42 6.39 x 10-6 
 0006915 apoptosis 15 1.90 x 10-4 
 0030198 extracellular matrix organization 5 1.67 x 10-4 
 0043066 negative regulation of apoptosis 12 1.11 x 10-5 
 0043124 negative regulation of I-kappaB kinase/NF-kappaB  2 4.14 x 10-4 
 0042994 cytoplasmic sequestering of transcription factors 2 2.26 x 10-4 
 0006355 regulation of transcription, DNA-dependent 46 3.10 x 10-6 
 0060056 mammary gland involution 3 7.93 x 10-8 
 0001843 neural tube closure 3 1.23 x 10-4 
 0006954 inflammatory response 10 1.23 x 10-4 
 0006935 chemotaxis 7 1.75 x 10-4 
 0007567 parturition 2 5.19 x 10-4 
     
Molecular Function 0003700 transcription factor activity 33 5.29 x 10-10 
 0008140 cAMP response element binding protein binding 3 2.60 x 10-6 
 0008009 chemokine activity 4 1.45 x 10-4 
 0005523 tropomyosin binding 3 1.23 x 10-4 
 0017022 myosin binding 3 3.86 x 10-4 
 0004887 thyroid hormone receptor activity 2 8.82 x 10-4 
 0043565 sequence specific DNA binding 20 2.78 x 10-7 
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Additionally, significantly enriched molecular functions were “transcription 
factor activity” GO:0003700 (p=5.29 x 10-10) and “sequence specific DNA-
binding” GO:0043565 (p=2.78 x 10-7). Further examination of these categories 
provided a list of over enriched transcription factors responsible for the 
transcription of the genes involved in the host response (Fig. 8-9). Finally, the 
biological process GO category contained significantly enriched genes in 
“negative regulation of apoptosis” (GO:0043066) (p=1.1 x 10-5), with 12 of the 
210 (5.7%) of the total significantly regulated genes in this node. Examination of 
this category found genes induced with increasing time at 60 min and 120 min 
adhesion of B. infantis that are directly related to the observed phenotype of the 
epithelial cell (Fig. 10). As such, mechanisms of the enriched apoptotic genes 
were visualized using signal transduction pathways to discern possible routes 
that explain the phenotype.  
To determine which network and signal cascade molecules were related, 
the list of significantly regulated genes analyzed as a set of pathways that 
mediate apoptosis with particular attention to networks related to GPCRs and 
gangliosides. In total, these analyses pointed to a set of genes associated with 
GPCRs and AKT signaling, which is a central regulatory molecule in many signal 
transduction pathways, including cell survival, and associated specific signaling 
molecules with cell surface receptors (Fig. 11). Overlaying the host gene 
expression data during B. infantis association found GPCRs and NF-!B to be 
regulated.  
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FIG. 7. GO Tree and Heat Map of Cellular Component; Nucleus during co-culture 
incubation. Multiple genes are listed as the gene chip contains multiple probesets 
for the same gene. The complete GO tree for cellular component is presented in 
Fig B.3. 
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FIG. 8  GO tree and heat map of the Molecular Function category Transcription 
Factor Activity during co-culture incubation. Multiple genes are listed as the gene 
chip contains multiple probe sets for the same gene. The complete GO tree for 
molecular function is presented in Fig. B.1 
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FIG. 9. GO tree and heat map of molecular function for sequence specific DNA-
Binding activity during co-culture incubation. Multiple genes are listed as the 
gene chip contains multiple probe sets for the same gene. The complete GO tree 
for molecular function is presented in Fig. B.1.  
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FIG. 10. GO tree and heat map of the biological process Negative Regulation of 
Apoptosis during co-culture incubation. The complete GO tree for biological 
process is presented in Fig. B.2. 
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FIG. 11. Potential surface receptors and signaling pathways. Red fill indicates significant (q<0.05) induction of gene 
expression resulting from B. infantis association. Shading of the fill indicates the intensity of increase in regulation.
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However, AKT gene expression was unchanged. NF-!B is a transcription 
factor and was implicated as involved in the transcription of the negative 
regulation of apoptosis genes during GO enrichment (Fig. 11). 
 Considering the direct signal transduction link between AKT and NF-!B a 
more focused analysis was done to more clearly define the specific interactions 
with membrane initiated induction as the beginning point (Fig. 12). Two GPCRs 
were induced, and tied with the increased expression of three genes GO analysis 
associated with the negative regulation of apoptosis. The induction of membrane 
bound cell signaling receptors by the presences of B. infantis lead to the 
hypothesis that GPR20 and GPR161 were the receptors bound by B. infantis 
adhesion to initiate AKT-mediated signaling to reduce cytotoxicity. To determine 
if these proteins were involved in host-microbe binding, an adhesion assay was 
done after blocking GPR161 and GPR20 with specific antibodies. Blocking 
GPR161 and GPR20 did not significantly (p>0.05) change the number of 
adherent bacteria adhered to the cell membrane, indicating that these two 
proteins are not acting as the binding site for B. infantis (Fig. 13). These 
observations eliminated GPR20 and GPR161 as adhesion partners for B. 
infantis, their role in the host-microbe relationship is still unknown, as are their 
potential to activate signaling cascades in the host cell. While GM1 was a 
receptor for B. infantis, the protein interaction remained unclear. Consequently, 
confirmation of AKT was pursued by measuring the protein level and activation 
state (i.e. phosphorylation) of specific signaling molecules up and down stream of 
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AKT were done to define the signaling network between the membrane and 
NF-!B. 
 
FIG. 12. G-protein coupled receptor signaling induced by B. infantis adhesion. 
Red fill shading indicates the intensity of gene expression induction during 
B. infantis in vitro association with gut epithelium. Red fill indicates significant 
(q<0.05) induction of gene expression resulting from B. infantis association. 
Shading of the fill indicates the intensity of increase in regulation.
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Fig. 13. Adhesion assay. Blocking of GPR161 and GPR20 did not decrease B. 
infantis binding, demonstrating they are not the receptors for adhesion. 
 
 
 Despite the unknown role of GPR20 and GPR161 (58, 96) and being ruled 
out as a receptor for B. infantis confirmation of the protein change was evaluated. 
The amount of GPR20 protein did not significantly change with B. infantis 
treatment over time. However, GPR161 protein content did increase with 
treatment and increased slightly over adhesion time (Fig. 14). 
 Transduction between GPCRs occurs via an adaptor protein (G!q) with 
PYK2. The protein level and phosphorylation status remained constant between 
treatments and with time of PYK2. Since the protein was constitutively 
phosphorylated, it suggests that GPCRs were constantly triggering activation due 
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FIG. 14. Images of western blots probing signaling cascade. Protein samples 
used in this experiment were total protein samples.  
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to established link between GPCRs to PYK2 (34). Unfortunately, the exact 
remains to be defined. However, it does indicate that membrane mediation via 
PYK2 is involved in B. infantis adhesion. Subsequently, examination of the 
protein level and phosphorylation status of PDK1, the next protein involved in 
AKT-mediate signaling was examined. The protein level of PDK1 remained 
constant during time and B. infantis treatment, as indicated with gene expression. 
However, phosphorylation of PDK1 at Ser241 increased with addition of B. 
infantis, suggesting that activation of PDK1 kinase activity (18) and subsequent 
phosphorylation of AKT (8, 100). 
 AKT, PKY2, and PDK1 are activated by phosphorylation, which enables 
the signaling cascade to progress (48, 130, 134). AKT1 protein concentration 
remained constant in the control and B. infantis treated cells. The host had a 
small amount of phosphorylation at Ser473 that decreased with time. In contrast, 
the phosphorylation status, and thereby activation status, of AKT increased at 
Ser473 and Thr308 with the addition of B. infantis (Fig. 14). Phosphorylation at 
both sites decreased with time. Thr308 phosphorylation of AKT was only 
observed in the B. infantis treated cells indicating that the bacterial adhesion led 
to full and complete activation of AKT. Without phosphorylation at Thr308 AKT 
activity is greatly reduced nearly to the point of loss of function, and as such 
phosphorylation at Thr308 is considered a master regulator for AKT activity 
(100). 
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 The gene expression results indicated induction of BIRC3 (cIAP2), 
TNFAIP3 (A20) and SERPINB9. SERPINB9 protein levels were not affected by 
B. infantis adhesion (Fig. 14), while both BIRC3 (cIAP2) and TNFAIP3 (A20) 
showed increased protein levels in the B. infantis treated cells at all time points.  
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CHAPTER IV 
DISCUSSION… 
 
 Adhesion of B. infantis to a host gut epithelial model significantly 
increased the survivability of the host cells. Although when B. infantis was mixed 
with Salmonella enterica ser. Typhimurium and added to the host cells a similar 
increase in cell survival was not observed. This indicates that B. infantis may 
protect host cells rather than rescue them from some challenge. Similar 
observations have been made with the probiotic Lactobacillus rhamnosus, 
another purported probiotic, when caco2 cells were treated with the probiotic and 
then challenged with Salmonella ser. Typhimurium (13). The authors did not 
show data or discuss if the host cells treated with L. rhamnosus showed 
decreased cytotoxicity, however. Contrary to these findings, Lee Do et al. (84) 
found that Bifidobacterium adolescentis, another probiotic microbe, generated 
peptidoglycan structures that inhibited caco2 cell growth in a dose dependent 
manner, while yet another study with B. adolescentis showed no increase 
influence to cell survivability in bacterial treated cells as compared to the control 
(45). Literature reports of specific molecular explanations of probiotic/host 
interactions contain conflicting and confusing reports. Consequently, this study 
sought to provide orthogonal methods of confirmation to prove specific molecular 
interactions and signaling routes. 
 Results from this study demonstrated an increased cell survival. 
Considering that contradictory results between B. infantis and B. adolescentis 
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treatment, it is likely that this trait is strain dependent. This strain difference 
points out the desperate need for genome sequencing and genetically defined 
models for understanding the molecular mechanisms underlying the complex 
host-microbe relationship as was done in this study. With the disparity of 
cytotoxic effects of other probiotics, it can reasonably be concluded that the 
increased host cell survival that is observed in B. infantis treated cells may not be 
novel, but certainly is significant as it has not been observed with other 
probiotics. Increased cell survival could be the underlying mechanism to the 
overall improvement in host health observed in humans harboring this probiotic. 
 It was found that B. infantis bound gangliosides. Gangliosides are 
glycolipids with a complex set of structures involved in lipid rafts (3) and are 
linked to neurological function. The terminal residue is often sialic acid (147). 
During viral and bacterial adhesion they are commonly used as a non-specific 
binding partner that enables close association that allows subsequent specific 
protein association for invasion (141, 142). They are also directly linked with 
triggering cellular signaling cascades (55, 97, 99). This result further encourages 
investigation of the host gene expression. 
 GO enrichment analysis of gene expression data generated from host 
cells treated with B. infantis revealed the biological process “negative regulation 
of apoptosis” to be significantly over-represented. Molecular function and cellular 
component GO results indicated that large transcriptional changes occurred as a 
result of B. infantis adhesion. 
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 Numerous other studies discussed the impact probiotics have on 
intestinal epithelial cell health and, attribute those effects to prevention of 
pathogenic adhesion, improved cell barrier function, absorption and metabolism 
of bacterial toxins, and the production of anti-microbial peptides (6, 12). However, 
these studies do not show that probiotics can actually increase cell survival as 
was indicated by this gene expression study and cytotoxicity assay. 
 Western blot analysis of the proteins implicated by the gene expression 
and GO enrichments to play a role in altering host cell survival revealed a likely 
mechanism by which the increase in survival was observed. Perhaps the most 
significant observation from this work is the complete activation of AKT. 
Substrate binding and increased rate of enymatic atalysis by AKT requires both 
Ser473 and Thr308 phosphorylation to occur with phosphorylation at Ser473 
often preceding and usually being a necessary pre-condition of phosphorylation 
at Thr308 (100, 130). Only in the B. infantis treated cells are both of the 
activation sites for AKT seen as phosphorylated leading to complete activation of 
the kinase.  
 Pathway analysis showed that AKT activation is related to the translation 
of three proteins with ties to increased cell survival (10, 62, 138, 139). Three 
proteins - cIAP2 (BIRC3), TNFAIP3 (A20) and SERPINB9 - were all induced in B. 
infantis treated cells, and not in the other cell treatments, with the exception 
being SERPINB9 as it was found in the control cells. These proteins are 
downstream of NF-KB and known inhibitors of caspases that are needed for 
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apoptosis (28, 33). Induction of these genes and proteins to block caspase 
activity is one explanation of increased cell survival with addition of B. infantis. 
 Other studies of probiotic interactions with host cells have queried AKT 
activation as well, but did not query AKT for complete activation. Yan et al. (155) 
showed that L. rhamnosus-treated cells led to the phosphorylation of AKT at 
Ser473. It was previously mentioned that for complete activation of AKT and 
subsequent signaling activity, AKT must be phosphorylated at both Ser473 and 
Thr308. Without being completely phosphorylated the ability of AKT to activate 
NF-KB and initiate NF-KB’s subsequent effect on host transcription is greatly 
reduced. Yan et al. did not test this and so conclusions about whether or not L. 
rhamnosus can fully activate AKT cannot be reached.  
 In light of the data from this work it is likely that activation of AKT and the 
subsequent translation of cell survival proteins would be observed in other 
probiotic systems. As previously mentioned, other studies attribute the increase 
in cell survival observed in probiotic treated cells to some of the other actions 
probiotics are observed to render to the host. No other study specifically 
postulated that the actual adherence of the probiotic to the host cell set off 
signaling cascades increasing host cell survival as has been demonstrated in this 
study.  
 The observed increase in protein concentration of proteins with known ties 
to increased cell survival a more complete picture of improved host health can be 
formed. In addition to likely excluding pathogenic bacteria from gaining access to 
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host cells, B. infantis adhesion increased the host cell survival rate, as well as 
responsible for producing anti-microbial compounds known to kill pathogens. The 
sum total of the production of anti-microbial compounds, physically excluding 
pathogenic bacteria, increasing production of cell survival proteins and 
suppression of inflammation is most likely results in the improved health 
observed in clinical trials and animal studies.  
 The implications of the identification of two GPCRs identified as involved 
in the signaling resulting in the increased cell survival of the host are unclear. 
Gene expression analysis shows these two receptors as potentially involved, 
while western blot analysis confirms the presence of these two receptors. 
GPR161 and GPR20 are both non-sensory, orphan GPCRs (58, 96). Orphan 
receptors are categorized as such because they do not have any known ligands 
(96). Very little work has been published on these two receptors. This study is the 
first to identify two GPCRs as potentially involved in the manifestation of the 
health benefits of probiotics. 
 Bioinformatic examination of the two receptors’ protein sequences using a 
transmembrane region predictor (60, 101, 102) and an N-glycosylation predictor 
(114) reveals two potential sites for N-linked glycosylation to occur (Figs. C.1-
C.2). N-linked glycans are post-translational modifications that result in the 
covalent bonding of complex oligosaccharides to asparagine residues in proteins. 
These glycans have a basic core structure Man3GlcNAc2Asn (147), followed by 
various other terminal sugars, including sialic acid. As previously discussed, 
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these carbohydrates are excellent binding partners for bacteria (11). 
Gangliosides are also often terminally modified with sialic acids (147), which 
have already been shown to be bound by B. infantis. The fact that both of these 
glycans share terminal sialic acids as a characteristic could provide a link 
between ganglioside binding and the implied involvement of these GPCRs in the 
adhesion of B. infants and subsequent cell signaling events that followed. The 
relationship between glycans, specifically human milk oligosaccharides, and B. 
infantis has been investigated demonstrating that carbohydrates are key binding 
structures for these bacteria and play a critical role in their metabolism and 
population establishment (92). Identification of these two cell-signaling surface 
receptors and their subsequent potential extra-cellular glycosylation sites point 
strongly that these two proteins may be the binding partners of B. infantis. 
Furthermore, even if these two proteins prove not to be the actual binding 
partners but instead the carbohydrates are, an entire group of known signaling 
proteins that do not have known ligands are now suspect as binding partners for 
not only B. infantis but other bacteria as well. While presence of these GPCRs is 
observed in the host cell, the exact sub cellular location of these receptors in this 
cell line is unknown. Also, while the total amount of GPR20 remains fairly 
constant across treatment levels and time, GPR161 is only observed in the B. 
infantis treated cells. This could indicate that while initially bound to gangliosides, 
which are concentrated on GPCRs, B. infants then binds GPR20 which then acts 
as the primary receptor initiating the signaling cascade, resulting in increased 
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expression of GPR161. As there is no known ligand for GPR161, it is possible 
that B. infantis adhesion induces the expression of this protein with the express 
purpose of using it to further establish itself on the host cellular surface. As the 
gut epithelial cells have basolateral and apical surfaces, to be the binding partner 
of the bacteria the proteins must be expressed on the apical surface. Further 
investigation of these signaling proteins as to their potential as binding partners 
of B. infantis while very likely, and was therefore tested with additional 
experimentation.  The results form these experiments showed that neither of 
these induced GPCRs was the binding site of B. infantis (Fig. 13).  
 In conclusion, this study demonstrated that adhesion of B. infantis to gut 
epithelial cells induced significantly higher survival as compared to control cells. 
Further investigation as to the underlying mechanisms behind this increase 
survival revealed that gangliosides are used for adhesion, while no protein was 
identified, in spite induction of two orphan g-protein coupled receptors. Signals 
transduced via PYK2 to AKT and ultimately to three anti-apoptotic factors. In 
total, B. infantis reduced cytotoxicity via AKT activation with dual 
phosphorylation. 
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CHAPTER V 
SUMMARY  
 
Hypothesis: 
Mammalian signal transduction via GPCR signaling instigated by adhesion 
of pathogenic bacteria leads to host cell signaling related to apoptosis, while of 
probiotic bacteria induces host cell signaling related to cell proliferation. 
Objectives:  
1. Adhere probiotic (Bifidobacterium infantis) and pathogenic (Salmonella 
ser. Typhimurium LT2) microbes to Caco2 intestinal cells and measure the 
gene expression of the signal transduction molecules.  
2. Conduct bioinformatic analysis of the gene expression changes to 
indentify the specific molecules for the associated with g-protein signaling.  
3. Candidate molecules will be verified using Western blot analysis. No more 
than 10 proteins will be verified in this objective. 
 Analysis of the gene expression data as well as the protein expression 
data demonstrated conclusively that indeed B. infantis adhesion leads to a 
drastically different cellular signal than cells adhered to Salmonella ser. 
Typhimirium. However, the data did not show that B. infantis adhesion resulted in 
proliferation, but instead an increase in cell survival (Fig. 15). It was seen that g-
protein coupled receptors were involved in the host cell signaling. In addition to 
the original objectives, all of which were performed as described, a cytotoxicity 
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FIG. 15. Proposed model of host reaction to B. infantis adhesion. As determined by the data gathered in this experiment, this proposed model shows what effect adhesion of B. infantis has on a 
host epithelial cell. Following adhesion and interaction with some unknown receptor, PYK2 is phosphorylated, leading to the subsequent activation of, also by phosphorylation, PDK1 and AKT. 
NFKB is the translocated to the nucleus where it is responsible for the induction of the proteins BIRC3 and TNFAIP3. These two proteins have been shown to decrease cell death (10, 28, 150). Via 
an undetermined pathway the orphan G-protein coupled receptor GPR161 is also induced, as indicated by the red fill, and expressed by the host cell. The significance of the expression of this 
receptor is not known, although it does not at as the receptor for B. infantis adhesion. According to western blot data, the phosphorylation cascade initiated by B. infantis adhesion has occurred 
within 30 minutes post adhesion and by 120 minutes post adhesion the levels of phosphorylated AKT have dropped. Production of BIRC3, TNFAIP3 and GPR161 were all observed within 30 
minutes
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assay and ganglioside adhesion assay were performed to understand the 
underlying mechanisms responsible for the induction of the survival genes.  
These additional studies shed much needed light on this study.  Due to the lack 
of evidence from the gene expression correlating with cell proliferation, as well as 
the decreased cytotoxicity that was observed, the original hypothesis was set 
aside and a pursuit of the signals responsible for the decreased cytotoxicity was 
undertaken.  We were successful in uncovering proteins responsible for the 
increase in cell survival and the signals perpetuated resulting in the increased 
translation of those proteins. 
 
Overview of Results 
 A human epithelial model, when adhered to by a known probiotic B. 
infantis displayed significant differences in the survival of those cells. Gene 
expression analysis implicated that three host genes, BIRC3, TNFAIP3 and 
SERPINB9 were induced in the host cells and likely the cause of the impact to 
cell survival seen in the cytotoxicity assay. The mechanism by which these genes 
were induced was predicted, tested, and proved. Adhesion to host cell 
gangliosides results in a signaling cascade initiated by unknown GPCRs at the 
cell surface resulted in the complete activation of AKT and subsequent increased 
expression of the genes and translation of these survival proteins.  
 
Impact of Work 
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 For the first time, a set of experiments has been conducted that will 
allow researchers to better assess the properties of bacteria that qualify them as 
a probiotic. Additionally, a model by which other bacterial species can be tested 
for their beneficial properties has been established that removes a great degree 
of complications that arise from animal or human subject systems. While these 
more advanced models still have a place in this field, I posit that it is a great 
benefit to gain insights and direction in a reduced variable system before 
engaging in a complicated and expensive adult animal model.  
 The next point that should be addressed is that it appears that the word 
commensal simply does not completely characterize the actual mode of 
interaction between host and non-pathogenic microbe. B. infantis was first placed 
in this group of neutral organisms, when clearly it is not a neutral organism (Fig. 
16). This work furthers the notion that the bacteria residing in the human gut are 
either doing our bodies some harm, or are doing them some good. While the 
pathogens have received the bulk of the scientific attention through the centuries, 
these commensals, if studied more in depth, may prove to not be merely sharing 
our table, but actively participating in the preservation of the host in which they 
reside.  
  
Future Work 
 Identification of the host receptor that is bound by B. infantis should be the 
focus of future work (Fig. 16). While these data suggested that GPR20 and 
GPR161 were likely involved in binding, the adhesion assay performed to assess 
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that showed otherwise. The role of these two receptors in the host response 
should also be evaluated. As this study identified a cell-signaling pathway that 
was activated by the presence of B. infantis what other signaling pathways are 
active due to the presence of these two cell surface receptors?  What impact, if 
any, do those pathways have on the health of the host?  Answering these 
questions would bring valuable information to the field and  
 
 
FIG. 16. Additions to field resulting from current study 
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further clarify the relationship between host and probiotic.  
 In summary, B. infantis adhesion to host cells lead to increased cell 
survival via cell signaling initiated by g-protein coupled receptors, through 
complete activation of AKT, and culminating in the translation of three proteins 
with described impacts on cell survival 
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Appendix A. TABLE A.1. Complete list of significantly differentially expressed 
host genes following adhesion of B. infanits 
 
Symbol Annotation Location Type(s) 
Log 
Ratio 
 CCL20 
 chemokine (C-C motif) 
ligand 20 
 Extracellular 
Space  cytokine -0.32 
 CXCL1 
 chemokine (C-X-C motif) 
ligand 1 (melanoma growth 
stimulating activity, alpha) 
 Extracellular 
Space  cytokine 0.079 
 CXCL2 
 chemokine (C-X-C motif) 
ligand 2 
 Extracellular 
Space  cytokine -0.402 
 CXCL3 
 chemokine (C-X-C motif) 
ligand 3 
 Extracellular 
Space  cytokine -0.015 
 IL6 
 interleukin 6 (interferon, 
beta 2) 
 Extracellular 
Space  cytokine -0.234 
 IL8  interleukin 8 
 Extracellular 
Space  cytokine 0.062 
 AGPAT4 
 1-acylglycerol-3-
phosphate O-
acyltransferase 4 
(lysophosphatidic acid 
acyltransferase, delta)  Cytoplasm  enzyme -0.406 
 ARL5B 
 ADP-ribosylation factor-
like 5B  unknown  enzyme -0.369 
 BIRC3 
 baculoviral IAP repeat-
containing 3  Cytoplasm  enzyme -0.243 
 CES4  carboxylesterase 4-like  Cytoplasm  enzyme -0.634 
 CYP1A1 
 cytochrome P450, family 
1, subfamily A, polypeptide 
1  Cytoplasm  enzyme -0.34 
 CYP1B1 
 cytochrome P450, family 
1, subfamily B, polypeptide 
1  Cytoplasm  enzyme -0.274 
 DLST 
 dihydrolipoamide S-
succinyltransferase (E2 
component of 2-oxo-
glutarate complex)  Cytoplasm  enzyme -0.616 
 G3BP1 
 GTPase activating protein 
(SH3 domain) binding 
protein 1  Nucleus  enzyme 0.489 
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Symbol Annotation Location Type(s) 
Log 
Ratio 
 GEM 
 GTP binding protein 
overexpressed in skeletal 
muscle 
 Plasma 
Membrane  enzyme 0.215 
 
HMGCS1 
 3-hydroxy-3-
methylglutaryl-Coenzyme 
A synthase 1 (soluble)  Cytoplasm  enzyme -0.215 
 LYZ 
 lysozyme (renal 
amyloidosis) 
 Extracellular 
Space  enzyme -0.888 
 MAGT1  magnesium transporter 1 
 Extracellular 
Space  enzyme -1.112 
 MGST1 
 microsomal glutathione S-
transferase 1  Cytoplasm  enzyme -0.527 
 OPA1 
 optic atrophy 1 (autosomal 
dominant)  Cytoplasm  enzyme -0.847 
 RAB2A 
 RAB2A, member RAS 
oncogene family  Cytoplasm  enzyme -1.12 
 RAB9A 
 RAB9A, member RAS 
oncogene family  Cytoplasm  enzyme -0.68 
 RHEB 
 Ras homolog enriched in 
brain 
 Plasma 
Membrane  enzyme -1.24 
 RHOV 
 ras homolog gene family, 
member V 
 Plasma 
Membrane  enzyme -0.062 
 RND1  Rho family GTPase 1  Cytoplasm  enzyme -0.171 
 SCD 
 stearoyl-CoA desaturase 
(delta-9-desaturase)  Cytoplasm  enzyme -0.887 
 SIAE  sialic acid acetylesterase  Cytoplasm  enzyme -3.026 
 SOD2 
 superoxide dismutase 2, 
mitochondrial  Cytoplasm  enzyme -1.274 
 TXN  thioredoxin  Cytoplasm  enzyme -1.496 
 UGCG 
 UDP-glucose ceramide 
glucosyltransferase  Cytoplasm  enzyme -0.342 
 
GPR109
B 
 G protein-coupled receptor 
109B 
 Plasma 
Membrane 
 G-
protein 
coupled 
receptor -0.224 
 GPR161 
 G protein-coupled receptor 
161 
 Plasma 
Membrane 
 G-
protein 
coupled -0.61 
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receptor 
Symbol Annotation Location Type(s) 
Log 
Ratio 
 GPR20 
 G protein-coupled receptor 
20 
 Plasma 
Membrane 
 G-
protein 
coupled 
receptor -0.485 
 AREG  amphiregulin 
 Extracellular 
Space 
 growth 
factor 0.334 
 EREG  epiregulin 
 Extracellular 
Space 
 growth 
factor 0.347 
 JAG1 
 jagged 1 (Alagille 
syndrome) 
 Extracellular 
Space 
 growth 
factor -0.488 
 LATS2 
 LATS, large tumor 
suppressor, homolog 2 
(Drosophila)  Nucleus  kinase 0.016 
 MAP3K7 
 mitogen-activated protein 
kinase kinase kinase 7  Cytoplasm  kinase -0.308 
 MAP3K8 
 mitogen-activated protein 
kinase kinase kinase 8  Cytoplasm  kinase -0.764 
 NUAK2 
 NUAK family, SNF1-like 
kinase, 2  unknown  kinase 0.177 
 NUCKS1 
 nuclear casein kinase and 
cyclin-dependent kinase 
substrate 1  Nucleus  kinase -1.993 
 PCK1 
 phosphoenolpyruvate 
carboxykinase 1 (soluble)  Cytoplasm  kinase 0.344 
 PDK4 
 pyruvate dehydrogenase 
kinase, isozyme 4  Cytoplasm  kinase 0.004 
 PIM1  pim-1 oncogene  Cytoplasm  kinase -0.03 
 RIOK1  RIO kinase 1 (yeast)  unknown  kinase -0.479 
 STYK1 
 serine/threonine/tyrosine 
kinase 1  Cytoplasm  kinase -0.831 
 NR4A1 
 nuclear receptor subfamily 
4, group A, member 1  Nucleus 
 ligand-
depende
nt 
nuclear 
receptor 0.707 
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Symbol Annotation Location Type(s) 
Log 
Ratio 
 NR4A2 
 nuclear receptor subfamily 
4, group A, member 2  Nucleus 
 ligand-
depende
nt 
nuclear 
receptor -0.125 
 NR4A3 
 nuclear receptor subfamily 
4, group A, member 3  Nucleus 
 ligand-
depende
nt 
nuclear 
receptor 0.156 
 NR4A3 
 nuclear receptor subfamily 
4, group A, member 3  Nucleus 
 ligand-
depende
nt 
nuclear 
receptor -0.01 
 ALCAM 
 activated leukocyte cell 
adhesion molecule 
 Plasma 
Membrane  other -0.613 
 APP 
 amyloid beta (A4) 
precursor protein 
 Plasma 
Membrane  other -0.122 
 AREGB  amphiregulin B  unknown  other 0.029 
 BRP44L  brain protein 44-like  Cytoplasm  other -0.272 
 
C10ORF
110 
 chromosome 10 open 
reading frame 110  unknown  other -0.721 
 
C11ORF
1 
 chromosome 11 open 
reading frame 1  Nucleus  other -1.343 
 
C17ORF
69 
 chromosome 17 open 
reading frame 69  unknown  other -0.225 
 
C2ORF5
6 
 chromosome 2 open 
reading frame 56  unknown  other -0.836 
 
C6ORF6
2 
 chromosome 6 open 
reading frame 62  unknown  other -1.095 
 CALD1  caldesmon 1  Cytoplasm  other -0.389 
 CALD1  caldesmon 1  Cytoplasm  other -0.179 
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 CALD1  caldesmon 1  Cytoplasm  other -0.544 
Symbol Annotation Location Type(s) 
Log 
Ratio 
 CARD10 
 caspase recruitment 
domain family, member 10  Cytoplasm  other -0.413 
 CCNI  cyclin I  unknown  other -0.621 
 CCNL1  cyclin L1  Nucleus  other -0.446 
 CD9  CD9 molecule 
 Plasma 
Membrane  other -0.079 
 
CDC37L1 
 cell division cycle 37 
homolog (S. cerevisiae)-
like 1  Cytoplasm  other -0.212 
 
CHMP4B 
 chromatin modifying 
protein 4B  Cytoplasm  other -1.19 
 COL1A2  collagen, type I, alpha 2 
 Extracellular 
Space  other 0.245 
 CYR61 
 cysteine-rich, angiogenic 
inducer, 61 
 Extracellular 
Space  other -0.115 
 CYR61 
 cysteine-rich, angiogenic 
inducer, 61 
 Extracellular 
Space  other 0.067 
 DCAF5 
 DDB1 and CUL4 
associated factor 5  unknown  other -0.545 
 DDIT4 
 DNA-damage-inducible 
transcript 4  Cytoplasm  other 0.088 
 DLC1  deleted in liver cancer 1  Cytoplasm  other -1.214 
 DNAL1 
 dynein, axonemal, light 
chain 1  unknown  other -1.065 
 DST  dystonin 
 Plasma 
Membrane  other 0.342 
 EFNA1  ephrin-A1 
 Plasma 
Membrane  other -0.222 
 EMP1 
 epithelial membrane 
protein 1 
 Plasma 
Membrane  other 0.024 
 
FAM134
B 
 family with sequence 
similarity 134, member B  unknown  other -0.667 
 FBXO45  F-box protein 45  unknown  other 0.026 
 FCF1 
(includes 
EG:5107
7) 
 FCF1 small subunit (SSU) 
processome component 
homolog (S. cerevisiae)  unknown  other -1.268 
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Symbol Annotation Location Type(s) 
Log 
Ratio 
 
FLJ1035
7 
 hypothetical protein 
FLJ10357  unknown  other -0.22 
 
FLJ3684
8  hypothetical LOC647115  unknown  other -1.371 
 
GADD45
A 
 growth arrest and DNA-
damage-inducible, alpha  Nucleus  other 0.242 
 
GADD45
B 
 growth arrest and DNA-
damage-inducible, beta  Cytoplasm  other -0.072 
 
GRAMD2 
 GRAM domain containing 
2  unknown  other -0.746 
 HABP4 
 hyaluronan binding protein 
4  Cytoplasm  other -0.244 
 HHLA2 
 HERV-H LTR-associating 
2  unknown  other -0.575 
 HINT3 
 histidine triad nucleotide 
binding protein 3  unknown  other -1.756 
 HOOK1 
 hook homolog 1 
(Drosophila)  Cytoplasm  other -1.049 
 
HSP90B1 
 heat shock protein 90kDa 
beta (Grp94), member 1  Cytoplasm  other -1.22 
 HSPA4L 
 heat shock 70kDa protein 
4-like  Cytoplasm  other -0.53 
 IER3 
 immediate early response 
3  Cytoplasm  other -0.573 
 IER3IP1 
 immediate early response 
3 interacting protein 1  unknown  other -0.945 
 IER5 
 immediate early response 
5  unknown  other -0.308 
 IER5L 
 immediate early response 
5-like  unknown  other 0.185 
 INPP5F 
 inositol polyphosphate-5-
phosphatase F  unknown  other -0.713 
 ISG15 
 ISG15 ubiquitin-like 
modifier 
 Extracellular 
Space  other -0.316 
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Symbol Annotation Location Type(s) 
Log 
Ratio 
 
ITPRIPL2 
 inositol 1,4,5-triphosphate 
receptor interacting 
protein-like 2  unknown  other -0.947 
 
KLHDC7
A 
 kelch domain containing 
7A  unknown  other 0.2 
 
LOC1001
28893 
 hypothetical protein 
LOC100128893  unknown  other 0.201 
 
LOC1001
30360 
 hypothetical 
LOC100130360  unknown  other -0.11 
 
LOC1002
92959  similar to hCG2042049  unknown  other -0.997 
 
LOC2844
54 
 hypothetical protein 
LOC284454  unknown  other 0.203 
 
LOC2856
28 
 hypothetical protein 
LOC285628  unknown  other -0.078 
 LONRF3 
 LON peptidase N-terminal 
domain and ring finger 3  unknown  other -0.456 
 MEX3A 
 mex-3 homolog A (C. 
elegans)  unknown  other -0.283 
 
MGC162
75 
 hypothetical protein 
MGC16275  unknown  other -0.755 
 MLLT4 
 myeloid/lymphoid or 
mixed-lineage leukemia 
(trithorax homolog, 
Drosophila); translocated 
to, 4  Nucleus  other -0.903 
 NFKBIA 
 nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 
inhibitor, alpha  Cytoplasm  other -0.211 
 PDLIM3  PDZ and LIM domain 3  Cytoplasm  other -0.49 
 PDLIM3  PDZ and LIM domain 3  Cytoplasm  other -0.017 
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 PEAR1 
 platelet endothelial 
aggregation receptor 1  unknown  other -0.408 
Symbol Annotation Location Type(s) 
Log 
Ratio 
 PER1 
 period homolog 1 
(Drosophila)  Nucleus  other 0.319 
 PLIN2  perilipin 2 
 Plasma 
Membrane  other -0.366 
 PSME4 
 proteasome (prosome, 
macropain) activator 
subunit 4  unknown  other -0.012 
 RGMA 
 RGM domain family, 
member A 
 Plasma 
Membrane  other -0.395 
 RP5-
1022P6.2 
 hypothetical protein 
KIAA1434  unknown  other -0.061 
 RPL27A  ribosomal protein L27a  Nucleus  other -1.232 
 RPL38 
(includes 
EG:6169)  ribosomal protein L38  Cytoplasm  other -1.016 
 RPS11  ribosomal protein S11  Cytoplasm  other -0.828 
 RTN4  reticulon 4  Cytoplasm  other -0.226 
 S100P 
 S100 calcium binding 
protein P  Cytoplasm  other -0.512 
 
SERPINB
9 
 serpin peptidase inhibitor, 
clade B (ovalbumin), 
member 9  Cytoplasm  other -0.851 
 SNCA 
 synuclein, alpha (non A4 
component of amyloid 
precursor)  Cytoplasm  other -0.728 
 SOCS3 
 suppressor of cytokine 
signaling 3  Cytoplasm  other 0.044 
 
SPATA2L 
 spermatogenesis 
associated 2-like  unknown  other -0.793 
 
SPATS2L 
 spermatogenesis 
associated, serine-rich 2-
like  unknown  other 0.121 
 
SPATS2L 
 spermatogenesis 
associated, serine-rich 2-
like  unknown  other 0.117 
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 SPON1 
 spondin 1, extracellular 
matrix protein 
 Extracellular 
Space  other -0.627 
 SPRED1 
 sprouty-related, EVH1 
domain containing 1 
 Plasma 
Membrane  other -0.054 
Symbol Annotation Location Type(s) 
Log 
Ratio 
 SSX2IP 
 synovial sarcoma, X 
breakpoint 2 interacting 
protein 
 Plasma 
Membrane  other -0.754 
 TAGLN  transgelin  Cytoplasm  other -0.629 
 TIPARP 
 TCDD-inducible poly(ADP-
ribose) polymerase  unknown  other -0.122 
 TM4SF1 
 transmembrane 4 L six 
family member 1 
 Plasma 
Membrane  other -0.517 
 
TMEM20
6 
 transmembrane protein 
206  unknown  other -0.852 
 TMEM49  transmembrane protein 49 
 Plasma 
Membrane  other -0.314 
 TMEM49  transmembrane protein 49 
 Plasma 
Membrane  other -0.137 
 TMTC2 
 transmembrane and 
tetratricopeptide repeat 
containing 2  Cytoplasm  other -0.293 
 TNFAIP3 
 tumor necrosis factor, 
alpha-induced protein 3  Nucleus  other 0.152 
 TNFAIP3 
 tumor necrosis factor, 
alpha-induced protein 3  Nucleus  other 0.065 
 TPM3  tropomyosin 3  Cytoplasm  other -0.64 
 
TRAF3IP
3 
 TRAF3 interacting protein 
3  unknown  other -0.367 
 WHSC1 
 Wolf-Hirschhorn syndrome 
candidate 1  Nucleus  other -0.346 
 ZNF295  zinc finger protein 295  Nucleus  other -0.312 
 PLAU 
 plasminogen activator, 
urokinase 
 Extracellular 
Space 
 
peptidas
e -0.173 
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 PSMB4 
 proteasome (prosome, 
macropain) subunit, beta 
type, 4  Cytoplasm 
 
peptidas
e -0.676 
 SPG7 
 spastic paraplegia 7 (pure 
and complicated autosomal 
recessive)  Cytoplasm 
 
peptidas
e -0.688 
Symbol Annotation Location Type(s) 
Log 
Ratio 
 DUSP4 
 dual specificity 
phosphatase 4  Nucleus 
 
phosphat
ase -0.105 
 PPP3CC 
 protein phosphatase 3 
(formerly 2B), catalytic 
subunit, gamma isoform  unknown 
 
phosphat
ase -0.503 
 ATF3 
 activating transcription 
factor 3  Nucleus 
 
transcript
ion 
regulator -0.298 
 ATF3 
 activating transcription 
factor 3  Nucleus 
 
transcript
ion 
regulator -0.063 
 
BHLHE4
0 
 basic helix-loop-helix 
family, member e40  Nucleus 
 
transcript
ion 
regulator 0.49 
 BTG2  BTG family, member 2  Nucleus 
 
transcript
ion 
regulator -0.062 
 CEBPD 
 CCAAT/enhancer binding 
protein (C/EBP), delta  Nucleus 
 
transcript
ion 
regulator 0.037 
 CREM 
 cAMP responsive element 
modulator  Nucleus 
 
transcript
ion 
regulator -0.01 
 CREM 
 cAMP responsive element 
modulator  Nucleus 
 
transcript
ion 
regulator -0.231 
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 CREM 
 cAMP responsive element 
modulator  Nucleus 
 
transcript
ion 
regulator -0.514 
 CREM 
 cAMP responsive element 
modulator  Nucleus 
 
transcript
ion 
regulator -0.353 
Symbol Annotation Location Type(s) 
Log 
Ratio 
 CSRNP1 
 cysteine-serine-rich 
nuclear protein 1  Nucleus 
 
transcript
ion 
regulator -0.212 
 CYLD 
 cylindromatosis (turban 
tumor syndrome)  Nucleus 
 
transcript
ion 
regulator -0.461 
 DLX1  distal-less homeobox 1  Nucleus 
 
transcript
ion 
regulator -0.336 
 EGR3  early growth response 3  Nucleus 
 
transcript
ion 
regulator -0.004 
 ELF3 
 E74-like factor 3 (ets 
domain transcription factor, 
epithelial-specific )  Nucleus 
 
transcript
ion 
regulator 0.286 
 ELF3 
 E74-like factor 3 (ets 
domain transcription factor, 
epithelial-specific )  Nucleus 
 
transcript
ion 
regulator 0.278 
 ELF3 
 E74-like factor 3 (ets 
domain transcription factor, 
epithelial-specific )  Nucleus 
 
transcript
ion 
regulator 0.381 
 ETS2 
 v-ets erythroblastosis virus 
E26 oncogene homolog 2 
(avian)  Nucleus 
 
transcript
ion 
regulator -0.1 
 GRLF1 
 glucocorticoid receptor 
DNA binding factor 1  Nucleus 
 
transcript -0.842 
  
110 
ion 
regulator 
 HEY1 
 hairy/enhancer-of-split 
related with YRPW motif 1  Nucleus 
 
transcript
ion 
regulator -0.23 
Symbol Annotation Location Type(s) 
Log 
Ratio 
 HOXA2  homeobox A2  Nucleus 
 
transcript
ion 
regulator 0.193 
 HOXA2  homeobox A2  Nucleus 
 
transcript
ion 
regulator -0.101 
 IRF1 
 interferon regulatory factor 
1  Nucleus 
 
transcript
ion 
regulator -0.236 
 IRF8 
 interferon regulatory factor 
8  Nucleus 
 
transcript
ion 
regulator -0.34 
 JUN  jun oncogene  Nucleus 
 
transcript
ion 
regulator 0.713 
 JUNB  jun B proto-oncogene  Nucleus 
 
transcript
ion 
regulator -0.316 
 KLF6  Kruppel-like factor 6  Nucleus 
 
transcript
ion 
regulator -0.113 
 KLF7 
 Kruppel-like factor 7 
(ubiquitous)  Nucleus 
 
transcript
ion 
regulator -0.401 
 LMCD1 
 LIM and cysteine-rich 
domains 1  Cytoplasm 
 
transcript -0.463 
  
111 
ion 
regulator 
 LMCD1 
 LIM and cysteine-rich 
domains 1  Cytoplasm 
 
transcript
ion 
regulator -0.02 
Symbol Annotation Location Type(s) 
Log 
Ratio 
 LMO1 
 LIM domain only 1 
(rhombotin 1)  Nucleus 
 
transcript
ion 
regulator -0.456 
 MAFF 
 v-maf musculoaponeurotic 
fibrosarcoma oncogene 
homolog F (avian)  Nucleus 
 
transcript
ion 
regulator 0.26 
 MAFF 
 v-maf musculoaponeurotic 
fibrosarcoma oncogene 
homolog F (avian)  Nucleus 
 
transcript
ion 
regulator -0.419 
 MBD2 
 methyl-CpG binding 
domain protein 2  Nucleus 
 
transcript
ion 
regulator -0.341 
 NFIL3 
 nuclear factor, interleukin 
3 regulated  Nucleus 
 
transcript
ion 
regulator 0.182 
 NFKB2 
 nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 2 
(p49/p100)  Nucleus 
 
transcript
ion 
regulator 0.415 
 NFKBIE 
 nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 
inhibitor, epsilon  Nucleus 
 
transcript
ion 
regulator -0.357 
 NFKBIZ 
 nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 
inhibitor, zeta  Nucleus 
 
transcript
ion 
regulator -0.454 
 NFKBIZ 
 nuclear factor of kappa 
light polypeptide gene 
enhancer in B-cells 
inhibitor, zeta  Nucleus 
 
transcript
ion 
regulator 0.539 
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 RCAN1  regulator of calcineurin 1  Nucleus 
 
transcript
ion 
regulator 0.108 
Symbol Annotation Location Type(s) 
Log 
Ratio 
 RCAN1  regulator of calcineurin 1  Nucleus 
 
transcript
ion 
regulator -0.919 
 REL 
 v-rel reticuloendotheliosis 
viral oncogene homolog 
(avian)  Nucleus 
 
transcript
ion 
regulator 0.012 
 SCML1 
(includes 
EG:6322) 
 sex comb on midleg-like 1 
(Drosophila)  Nucleus 
 
transcript
ion 
regulator -0.49 
 
SERTAD
2 
 SERTA domain containing 
2  Cytoplasm 
 
transcript
ion 
regulator -0.051 
 SOX7 
 SRY (sex determining 
region Y)-box 7  Nucleus 
 
transcript
ion 
regulator 0.325 
 SPEN 
 spen homolog, 
transcriptional regulator 
(Drosophila)  Nucleus 
 
transcript
ion 
regulator -1.554 
 TLE1 
 transducin-like enhancer 
of split 1 (E(sp1) homolog, 
Drosophila)  Nucleus 
 
transcript
ion 
regulator -0.434 
 
TSC22D1 
 TSC22 domain family, 
member 1  Nucleus 
 
transcript
ion 
regulator -0.234 
 ZNF397  zinc finger protein 397  Nucleus 
 
transcript
ion 
regulator -0.796 
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 ZNF689  zinc finger protein 689  Nucleus 
 
transcript
ion 
regulator -0.042 
Symbol Annotation Location Type(s) 
Log 
Ratio 
 EEF1D 
 eukaryotic translation 
elongation factor 1 delta 
(guanine nucleotide 
exchange protein)  Cytoplasm 
 
translatio
n 
regulator -1.006 
 EIF5B 
 eukaryotic translation 
initiation factor 5B  Cytoplasm 
 
translatio
n 
regulator -0.945 
 ALB  albumin 
 Extracellular 
Space 
 
transport
er -1.771 
 AP2B1 
 adaptor-related protein 
complex 2, beta 1 subunit  Cytoplasm 
 
transport
er -0.598 
 
ATP6V0E
1 
 ATPase, H+ transporting, 
lysosomal 9kDa, V0 
subunit e1  Cytoplasm 
 
transport
er -1.295 
 FABP1 
 fatty acid binding protein 
1, liver  Cytoplasm 
 
transport
er -1.28 
 GLTP  glycolipid transfer protein  Cytoplasm 
 
transport
er -0.865 
 
SLC25A2
5 
 solute carrier family 25 
(mitochondrial carrier; 
phosphate carrier), 
member 25  Cytoplasm 
 
transport
er -0.179 
 VPS13A 
 vacuolar protein sorting 13 
homolog A (S. cerevisiae)  Cytoplasm 
 
transport
er 0.027 
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APPENDIX B. GO Trees 
 
FIG. B.1. GO Tree of Molecular Function
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FIG. B.3. GO Tree of Cellular Component
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APPENDIX C. GPCR Protein Analsysis  
A)  
 
 
FIGS. C.1.-C.2. GPR20 and GPR161 protein analysis 
A) GPR161 transmembrane regions (http://bp.nuap.nagoya-u.ac.jp/sosui/cgi-
bin/adv_sosui.cgi)  and N-linked glycosylation sites 
(http://www.cbs.dtu.dk/services/NetNGlyc/) as predicted based on sequence. 
Red asterisks indicate predicted location of extra-cellular N-linked glycosylation 
sites. Tan area indicates membrane of cell, while uppermost blue field represents 
the extra-cellular space, with the lower blue field the intra-cellular space. 
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B) 
 
 
B) Similar plot as shown in A), for GPR20. 
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